EVALUATING THE SUB-LETHAL TOXICITY OF THE ORGANOPHOSPHATE PESTICIDE, CHLORPYRIFOS, ON THE AMPHIBIAN, XENOPUS LAEVIS by Baldwin, Nicole Perras 1993-
 
 
EVALUATING THE SUB-LETHAL TOXICITY OF THE ORGANOPHOSPHATE 






A Thesis Submitted to the College of  
Graduate and Postdoctoral Studies  
In Partial Fulfillment of the Requirements  
For the Degree of Master of Science  
In the Toxicology Graduate Program  
University of Saskatchewan  


















PERMISSION TO USE 
 
 In presenting this thesis in partial fulfillment of the requirements for a postgraduate 
degree from the University of Saskatchewan, I agree that the Libraries of the University may 
make freely available for inspection. I further agree that permission for copying of this thesis in 
any manner, in whole or in part, for scholarly purpose may be granted by the professors who 
supervised my thesis work or, in their absence, by the Head of the Department of the Dean of the 
College in which my thesis work was done. It is understood that any copying or publication of 
use of this thesis or parts thereof for financial gain shall not be allowed without my written 
permission. It is also understood that due recognition shall be given to me and the University of 
Saskatchewan in any scholarly use which may be made of any material in my thesis.  
 Requests for permission to copy or to make other use of material in this thesis in whole or 
parts should be addressed to:  
 
Chair of the Toxicology Graduate Program  
Toxicology Centre  
University of Saskatchewan  
44 Campus Drive  
Saskatoon, Saskatchewan  
S7N 5B3  
 
Dean  
College of Graduate and Postdoctoral Studies  
University of Saskatchewan  
116 Thorvaldson Building, 110 Science Place  
Saskatoon, Saskatchewan  









Chlorpyrifos (CPF) is an organophosphate pesticide used extensively in Canada and 
around the world. Due to its highly conserved mechanism of action involving inhibition of 
acetylcholinesterase (AChE), CPF has the ability to exert toxicity on non-target species in 
aquatic systems. In fish species, exposure to CPF has been associated with a range of adverse 
effects across physiological endpoints including abnormal development, inhibition of AChE, 
immunomodulation, and molecular level effects such as altered expression of specific genes and 
global transcriptomes. However, the literature on amphibians exposed to CPF is not as extensive 
despite the known global declines of amphibian species and the hypothesized links between 
these declines and anthropogenic pesticide contamination of aquatic systems worldwide. The 
overall objective of this thesis was to gain a better understanding of the sub-lethal effects of CPF 
exposure on the model amphibian, Xenopus laevis, across levels of biological organization from 
molecular to whole animal.  
The first study (Chapter 2) examined the molecular toxicity pathways and mechanisms of 
toxicity after short-term exposure of early life-stage (ELS) X. laevis to CPF using whole body 
transcriptome analyses. The ELS transcriptomic responses were then compared to apical 
outcomes of chronic exposure to CPF to determine if identified dysregulated pathways could 
provide early indicators of these adverse outcomes. Post-hatch individuals were exposed to 
nominal CPF concentrations of 0.4, 2, or 10 μg L-1. A subset of individuals were sampled at 96 
hours (h) for whole-body transcriptomic analysis and remaining individuals were transferred to 
tanks for long-term exposure through to metamorphic climax (~ 75 days). Pathway analysis 
revealed dysregulated pathways that were related to outcomes known to be associated with 
exposure to CPF such as altered serine hydrolase activity, impacted metabolic processes, and 
immune-related outcomes. Other dysregulated pathways with less precedence in the literature 
included vasculature development and sensory perception of light stimulus. Apical outcomes of 
chronic CPF exposure included inhibition of AChE activity, increased relative liver weight, and 
a decrease in percentage of individuals that reached metamorphic climax. Dysregulation of 
serine hydrolase associated pathways after ELS CPF exposure is in agreeance with the decrease 
in AChE (a serine hydrolase enzyme) activity observed in the brains of individuals at 
metamorphic climax. Additionally, an increase in relative liver weight after chronic CPF 
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exposure could be related to dysregulation of ELS pathways associated with metabolic processes 
and immune function. In fact, several pathways related to immune function were depleted. 
In Chapter 3, we more closely examined the potential immunotoxicity of sub-lethal CPF 
exposure. Post-metamorphic individuals were exposed 1 or 10 μg L-1 CPF (nominal) for 7 days 
(d), then administered a phosphate buffered sodium (PBS) control injection or a 
lipopolysaccharide (LPS) injection to stimulate an inflammatory response. At 24 h post-
injection, morphometric indices were recorded and tissues were sampled for differential 
leukocyte counts (flow cytometry), liver pro-inflammatory cytokine expression (qPCR), and 
kidney histopathology. At 1 µg L−1 CPF, there was a decrease in circulating lymphocytes, an 
increase in circulating granulocytes, and an increase in the granulocyte:lymphocyte (GL) ratio 
regardless of immune state. Liver expression of pro-inflammatory cytokines TNF-α and CSF-1 
was increased in individuals exposed to 10 µg L−1 CPF, independent of immune state. Exposure 
to 10 μg L-1 CPF increased kidney epithelial cell height (by 18 %) and decreased lumen space in 
the convoluted tubules of the kidney. This study provided evidence that exposure to CPF can 
lead to changes in key biomarkers of immune status in amphibians in both immune-rested (PBS-
injected) and immune-stimulated (LPS-injected) states. Additionally, we found that LPS was an 
effective mitogen in our study, capable of inducing a robust and measurable stress response in X. 
laevis. This response included a decrease in circulating lymphocytes, and increase in circulating 
monocytes, and an increase in the GL ratio. In addition, increased liver expression of pro-
inflammatory cytokines TNF-α, IL-1β, and CSF-1 was induced by LPS injection. We conclude 
that LPS is an appropriate immunostimulatory agent in an immune challenge assay using X. 
laevis and that exposure to CPF does not appear to impact the response to LPS exposure.  
Overall, our findings show that exposure to environmentally relevant concentrations of 
CPF has the ability to impact amphibians at multiple levels of biological organization. A number 
of affected molecular pathways warrant further study in terms of the underlying mechanisms of 
CPF-mediated toxicity as well as the associated outcomes of CPF exposure in amphibians. This 
research provides novel data on the effects of CPF exposure to amphibians, which are generally 
overlooked and under-represented in the literature despite links between pesticide exposure and 
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This thesis is organized and formatted to follow the University of Saskatchewan College 
of Graduate Studies and Research guidelines for a manuscript-style thesis. Therefore, there is 
some repetition between the material presented in each chapter. Chapter 1 is a general 
introduction and literature review, including project goals and objectives. Chapter 4 is a general 
discussion and overall conclusion. Chapters 2 and 3 are organized as manuscripts for publication 
in peer-reviewed scientific journals and a description of author contributions is provided in the 
preface for these chapters. References cited in each chapter are combined and listed in the 
References section of the thesis. Supporting information associated with the research chapters 










Chapter 1 is a review of the available literature regarding the topics of chlorpyrifos, it’s 
physicochemical properties, fate in the environment, mechanism of toxic action, as well as 
toxicity to aquatic organisms, and the current state of knowledge regarding the effects of 
chlorpyrifos on various amphibian species. Chapter 1 also includes the overall goals and 






1.1.1 Usage and application rates 
Chlorpyrifos (CPF) [O, O-diethyl O-3,5,6-trichloro-2-pyridinyl phosphorothioate] is an 
organophosphate (OP) insecticide, acaricide, and miticide used in Canada and worldwide in both 
agricultural and commercial settings. It is one of the most widely used pesticides globally 
(Solomon et al., 2014). Chlorpyrifos was first manufactured and distributed by the Dow 
Chemical Company in 1965 and it’s use increased significantly in the early 1970s with the 
banning of dichlorodiphenyltrichloroethane (DDT) (Lee, 2017). Currently, usage of CPF in 
Canada is being re-evaluated as a part of the Pest Management Regulatory Agency’s (PMRA) 
initiative to re-evaluate active ingredients registered prior to 1995 with identified potential risk 
issues (PMRA, 2018). According to the manufacturer, CPF is authorized for use in almost 100 
countries worldwide on more than 50 different types of crops (Dow AgroSciences, 2018). The 
global demand for CPF was projected to be 200 000 tonnes in 2015 and the production and 
consumption of the pesticide are increasing each year (John and Shaike, 2015). Application of 
CPF is done by ground or aerial equipment and the chemical is sold in a variety of forms 
including liquid, gel, granular, soluble, emulsifiable, and flowable concentrates, 
microencapsulated material, pellets, tablets, impregnated materials, baits, wettable powders, 
dusts, and ready-to-use formulations (Dow AgroSciences, 2018; John and Shaike, 2015). In 
Canada and the United States, homeowner use and commercial use around residential areas has 
been largely restricted or eliminated due to concerns surrounding human neurotoxicity after 
exposure (CCME, 2008; US EPA, 2018). In 2012, the United States Environmental Protection 
Agency (US EPA) limited the use of CPF by lowering the acceptable application rates and 
creating buffer zones around public spaces where the pesticide cannot be sprayed (US EPA, 
2012). Regulations in Canada set forth by the PMRA dictate that spray buffer zones of 28-74 m, 
dependent on application method and rate, are to be maintained around aquatic ecosystems 
during agricultural use of CPF (PMRA, 2003).  
1.1.2 Physicochemical properties and mechanism of action 
The half-life of CPF is 30-50 days (d) in surface waters, 7-120 d in soil, and 39-200 d in 
sediment (Mackay et al., 2014; Racke, 1993). However, studies have shown that the aquatic half-
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life of CPF can vary greatly with water quality parameters such as pH; for example, at pH 9, 7, 
and 5 the half-life of CPF ranges from 16, 72-81, and 73 d, respectively (Racke 1993). It is 
considered to have low to moderate water solubility with a range of 1.4-2 mg L−1 at 25°C (John 
and Shaike, 2015). The octanol-water partition coefficient (log Kow) of CPF ranges from 3.31-
5.27, indicating an affinity for lipids (CCME, 2008). The potential for bioconcentration in biota 
varies with species, exposure duration, and dose. The bioconcentration factor (BCF) of CPF 
ranges from 100-4667 under field conditions and 58-5100 in laboratory settings, indicating a 
moderate to very high potential for bioconcentration in fish (CCME, 2008; Franke et al., 1994; 





Table 1.1. Physicochemical properties of chlorpyrifos under laboratory and field conditions. 
Property Units Value Reference 
Melting point ºC 36-38  
Molar mass g mol-1 350.59  
Vapour pressure mmHg 1.87x10-5 (Gebremariam et al., 2012) 




(John and Shaike, 2015) 
(Mackay et al., 2014) 










(Mackay et al., 2014) 
(Racke, 1993) 




(Mackay et al., 2014) 
(Racke, 1993) 
Half-life in soil days 7-120* (Mackay et al., 2014) 
log Kow  3.31-5.27 (CCME, 2008) 




(*) indicates laboratory conditions; (†) indicates field conditions 





 Organophosphate pesticides, such as CPF, target the enzyme acetylcholinesterase 
(AChE), which is responsible for hydrolysis of the neurotransmitter acetylcholine (ACh) in 
cholinergic synapses at neuromuscular junctions (Fukuto, 1990). Specifically, AChE inhibition 
occurs via a chemical reaction in which the serine hydroxyl moiety in the enzyme active site is 
phosphorylated. The phosphorylated serine hydroxyl group is no longer able to participate in the 
breakdown of ACh by hydrolysis (Fukuto, 1990). In target species, this inhibition leads to an 
accumulation of ACh at the neuromuscular junctions of nerve synapses, causing the desired 
effects through repeated and uncontrolled firing of neurons eventually leading to loss of 
respiratory control and death by asphyxiation (Costa, 2006; Sparling and Fellers, 2007). 
However, the neurotransmitter action of ACh and the role of AChE in the post-synaptic 
breakdown of ACh is conserved across species and as such, the mechanisms and adverse effects 
of CPF exposure is manifested in both target and non-target species (Fukuto, 1990; Giesy et al., 
2014). The AChE enzyme is present in and has been isolated from numerous non-target species 
across various taxa including mammals, fish, birds, reptiles, amphibians, and insects (Fukuto, 
1990). A decrease in AChE activity after CPF exposure has been reported across life stages in 
amphibian species including Rhinella arenarum (Liendro et al., 2015), Xenopus laevis (Richards 
and Kendall, 2002; Wacksman et al., 2006), Peudacris regilla, Rana boylii (Sparling and Fellers, 
2009), Rana sphenocephala (Widder and Bidwell, 2006, 2008), Hyla chrysoscelis, Acris 
crepitans, and Gastrophryne olivacea (Widder and Bidwell, 2008). These studies are evidence 
that CPF mechanism of action is conserved across amphibian species.  
 Although the phosphorylated enzyme is highly stable, recovery of AChE inhibited by 
CPF has also been demonstrated in a number of sub-lethal exposure scenarios in non-target 
organisms (Costa, 2006; Giddings et al., 2014). Additionally, chronic exposure to OPs generally 
results in tolerance to the cholinergic effects of these chemicals (Costa, 2006). Studies have 
shown that CPF exposure has the ability to elicit neurotoxicity prior to innervation of the 
cholinergic system, which suggests that there are multiple mechanisms of toxicity (Richards and 
Kendall, 2002). For example, a study where fetal rat brain cells were exposed to CPF reported 
altered cell numbers and packing densities in the brain that could not be explained by inhibition 
of AChE and subsequent cholinergic stimulation (Campbell et al., 1997). In humans, CPF is 
known to cause a syndrome unrelated to AChE inhibition (Organophosphate-Induced Delayed 
Polyneuropathy), which again demonstrates that toxic action of CPF can be unrelated to 
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inhibition of the enzyme (Costa, 2006; Lotti and Moretto, 2005). Additionally, multiple studies 
using AChE knockout mice exposed to OP pesticides showed the chemical has other potential 
targets of toxic action including butyrylcholinesterase, muscarinic receptors, adenylyl cyclase, 
acylpeptide hydrolase, and neuropathy target esterase (Duysen et al., 2001; Lockridge et al., 
2005). These findings indicate that there are several important underlying mechanisms that can 
contribute to adverse effects of CPF exposure. 
Metabolic activation and detoxification of CPF occurs primarily in the liver in fish 
species, although similar activity has been reported in other tissues including brain and intestine  
(ATSDR, 1997; Bonansea et al., 2017). Phase I biotransformation mediated by cytochrome P450 
monooxygenase enzymes results in the oxon-analog of CPF, a more potent cholinesterase-
inhibitor than the parent compound (Fukuto 1990; Wacksman et al., 2006). In fact, the formation 
of the oxon-analog from CPF is essential to the potency of the chemical, as the parent compound 
itself is not considered to be a strong inhibitor of AChE (Solomon et al., 2014). Other phase 1 
biotransformation pathways such as hydrolysis via carboxylesterases produce degradation 
products that are less toxic than the parent compound and are eventually excreted (Wacksman et 
al., 2006). In addition to this biotransformation within the liver of the exposed individual, 
bacteria and other environmental factors can also convert CPF into its oxon-analog, making it 
available for uptake from the environment (Sparling and Fellers, 2007). A number of CPF 
degradation products are considered more toxic than the parent compound including the oxon-
analog and the secondary metabolite 3,5,6trichloro-2-pyridinol (TCP) (Fig. 1.1; John and Shaike, 






Figure 1.1.  Biotransformation pathways of chlorpyrifos. Biotransformation occurs primarily in 
the liver, brain, and intestine in aquatic vertebrates. Structures in the yellow boxes are 
dialkylphosphate metabolites that are non-inhibitory and excreted in the urine. Structures in the 
red boxes are chlorpyrifos-adducted BchE, one example of a serine active-site enzyme that is 




1.1.3 Environmental fate and occurrence in aquatic environments 
 Measurable levels of CPF have been reported in a variety of environmental mediums 
including marine sediments, streams, sumps, sloughs, rivers, urban storm drains, freshwater 
lakes, groundwater, fog, rain, and air around the world (Gebremariam et al., 2012). Chlorpyrifos 
is also involved in long range transport, and concentrations of the pesticide have been measured 
at locations distant from point sources (Mackay et al., 2014). In fact, samples taken from remote 
places including snow from Alaskan arctic estuaries and sea-ice from the Bering Sea have 
reported measurable CPF concentrations although there would be no CPF applications in the 
region (Muir et al., 2004).  
 Following soil or foliar application, CPF can be distributed to different environments. 
Degradation after application generally occurs through microbial processes, hydrolysis, and 
photolytic mechanisms (Gebremariam et al., 2012). Due to its relatively low water solubility and 
moderate vapour pressure, the pesticide exhibits a tendency to adsorb to soil, sediment, and 
organic matter (Gebremariam et al., 2012). The water-soil adsorption coefficient of CPF ranges 
between 973-31000 mL g−1 with a mean of 8216 mL g−1 indicating that it strongly adsorbs to soil 
(Solomon et al., 2014). Once adsorbed, the persistence of CPF is greatly increased as the 
chemical is less available for degradation (Bondarenko and Gan, 2004; John and Shaike, 2015) 
and adsorption to soil represents a major route by which the chemical can enter aquatic systems 
(Gebremariam et al., 2012; Williams et al., 2014). Once in these systems, CPF adsorbs to 
sediments where it can then be released into the water through erosion to interact with non-target 
species living in affected environments (Gebremariam et al., 2012). Chlorpyrifos is considered 
persistent in aquatic sediments (Bondarenko and Gan, 2004). Along with adsorption to soils and 
sediments, there are several other routes by which CPF can make its way into aquatic ecosystems 
directly. These include spray drift, foliar wash-off, and, in some cases, direct application (Díaz-
Resendiz et al., 2015; Jin et al., 2015; John and Shaike, 2015). Numerous studies have measured 
CPF concentrations in various aquatic systems around the world, with concentrations as high as 
3.7 µg L−1 being recently reported from agriculturally intensive areas in North America (Uniyal 
and Kumar Sharma, 2018). The Canadian Council of Ministers of the Environment (CCME) has 
set the maximum allowable concentration of CPF for protection of aquatic life in surface fresh 
water at 0.02 μg L-1 for short-term exposures and 0.002 μg L-1 for long-term exposures (CCME, 
2008). In 2003, Environment Canada implemented the first nation-wide water surveillance 
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program for pesticides in Canada, which includes monitoring CPF levels. Detected 
concentrations of CPF in Canadian surface waters ranged from <0.0000005 to 0.205 µg L−1 with 
the highest concentrations reported in samples taken from the Ontario region (CCME, 2008). 
1.2 Toxicity of chlorpyrifos 
1.2.1 Toxicity to aquatic organisms 
The World Health Organization (WHO) classifies CPF as R50/53, which means that it is 
considered very toxic to aquatic animals with the potential to cause long-term adverse effects in 
aquatic environments (WHO, 2015). Giddings et al. (2014) performed a comprehensive review 
of available CPF literature and an ecotoxicological risk assessment for aquatic taxa and found 
that crustaceans were the most sensitive, followed by insects and then fish. Literature values for 
23 species of crustacea and 25 species of fish were evaluated. Median lethal dose (LC50) values 
at 96 hours (h) for crustacea ranged from 0.035 to 457µg L−1 CPF. In fish species, 96 h LC50 
values ranged from 0.53 to >806 µg L−1 CPF (Giddings et al., 2014). In this same review it was 
noted that there was a lack of good quality data on CPF toxicity to amphibians and, as such, 
amphibians were not included in the ecotoxicological risk assessment. A study by (Sparling and 
Fellers, 2007) reported 96 h LC50 values for CPF as 1 µg L−1 in Bufo americanus and 3 mg L−1 
in Rana pipiens. For the laboratory model amphibian Xenopus laevis, the CPF 96 h LC50 was 
560 µg L−1 for metamorphs, 2410 µg L−1 for early embryos, and 14600 µg L−1 for premetamorphs 
(El-Merhibi et al., 2004; Richards and Kendall, 2002).  
 A wide range of sub-lethal effects have been reported in non-target aquatic species 
exposed to CPF including developmental delays and abnormalities (Jin et al., 2015; Kienle et al., 
2009; Richards and Kendall, 2003), histological abnormalities across a range of organs 
(Colombo et al., 2005; Kunjamma et al., 2008; Scheil et al., 2009; Xing et al., 2012), inhibition 
of AChE activity (Colombo et al., 2005; Jin et al., 2015; Liendro et al., 2015; Richards and 
Kendall, 2002), immunologic effects (Adel et al., 2017; Jin et al., 2015; Kerby and Storfer, 2009; 
Maharajan et al., 2017), oxidative stress and reactive oxygen species (ROS) production (Liendro 
et al., 2015; Xing et al., 2012; Zhang et al., 2017), as well as molecular level changes including 
altered expression of specific genes and global transcriptomes (Wang et al., 2018; Zhang et al., 
2017). There are a number of factors which ultimately influence the outcomes of exposure to 
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CPF in non-target organisms. Frequency, duration, and intervals between exposures to CPF will 
influence responses observed. The relationship between duration of exposure to CPF and toxicity 
observed is reciprocal – that is, shorter exposures at higher concentrations result in the same 
level of response as longer exposures at lower concentrations (Giddings et al., 2014). 
Additionally, inter- and intra-species differences can impact outcomes of CPF exposure. For 
example, a study by Watson et al. (2014) compared morphological abnormalities in zebrafish 
and X. laevis larvae after CPF exposure and concluded that the amphibian species was more 
sensitive based on that particular endpoint. Life stage also plays an important role in CPF-
mediated toxicity, especially in amphibian species due to their unique life cycle. In studies with 
X. laevis exposed to CPF, metamorphs were the most sensitive life stage based on 96 h half-
maximal effective concentration (EC50) for CPF-induced malformations, followed by embryos, 
and then premetamorphs (El-Merhibi et al., 2004; Richards and Kendall, 2002). 
1.2.2 Immunomodulatory effects of chlorpyrifos  
 Immunomodulatory effects of CPF have been reported in a number of fish species (Chen 
et al., 2014; Díaz-Resendiz et al., 2015; Jin et al., 2015; Li et al., 2013; Ural, 2013; Wang et al., 
2011; Zhang et al., 2017). The immunomodulatory effects of CPF on amphibians are not as 
extensively researched, although Kerby and Storfer (2009) reported an increase in susceptibility 
to viral infection and larval mortality after exposure of Ambystoma tigrinum to CPF. Due to the 
conserved nature of many components of the innate immune system across jawed vertebrates 
(Riera Romo et al., 2016), immunological assays have been adapted for use across taxa and it is 
proposed that immunomodulating effects of chemicals in one animal model could serve to 
predict the immunotoxicity in other animals (Zelikoff, 1998). However, there are a number of 
reasons why amphibian species should be considered separately. One of the main reasons is the 
unique amphibian life stage of metamorphosis, when the immune system undergoes widespread 
remodeling and the organism is particularly vulnerable to exposure to both environmental 
contaminants and biological stressors (Robert and Ohta, 2009; Rollins-Smith, 1998). Another 
important consideration is the potential disease-driven mechanisms of global amphibian declines. 
In a host-resistance study conducted by Kerby and Storfer (2009) on tiger salamanders, it was 
found that exposure to 200 µg L−1 of CPF decreased larval survival rate by 20%. When combined 
with exposure to Ambystoma tigrinum virus (ATV) larval survival decreased by >60% at the 
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same concentration and the combination of ATV and CPF resulted in lower survival rates and 
higher infection rates at concentrations as low as 2 µg L−1 (Kerby and Storfer, 2009). 
 The mechanisms underlying CPF immunotoxicity in aquatic vertebrates, including 
amphibian species, are largely unknown. A putative mechanism of action suggests that the 
immunotoxicity of CPF is related to the well-characterized CPF-induced production of ROS, 
which can then induce cellular destruction via apoptosis of effector cells of innate immunity, 
such as leukocytes (Marchand et al., 2017). In a study by Ural (2013), common carp exposed to 
CPF demonstrated increased white blood cell count and altered expression and activity of 
antioxidant enzymes across a range of tissues; however, when an antioxidant agent, Lycopene, 
was administered concurrently with CPF exposure these toxic effects were neutralized. This 
supports the theory that ROS-mediated damage to effector cells of innate immunity, such as 
white blood cells, is an underlying mechanism of immunotoxicity (Ural, 2013). 
1.3 Amphibians in the environment  
1.3.1 Amphibian significance and status of decline 
 Often overlooked and underrepresented in the literature is the vast array of amphibian 
species that play a vital role in aquatic ecosystems in Canada, and around the world. In addition 
to being an important food source for higher trophic organisms, larval amphibians play vital 
roles as primary consumers, detritivores, as well as predators (Blaustein and Kiesecker, 2002; 
Hocking and Babbitt, 2014). Moreover, due to their unique ecothermic physiology, amphibians 
can exploit resources that are typically seen as “energy-poor”. This creates a valuable link 
between the lowest and highest trophic levels in a community (Hopkins, 2007). 
Declines in amphibian populations have been noted from various locations worldwide 
since the early 1980s and were first recognized as a global issue in the early 1990s (Blaustein, 
1994; Carey et al., 1999; Hayes et al., 2010). In 2004, a global assessment by the International 
Union for Conservation of Nature (IUCN) found that 32.5% of amphibian species are considered 
threatened and at least 43.2% of all amphibian species are known to be experiencing some form 
of population decrease (Stuart et al., 2004). In addition, the IUCN found that a much higher 
proportion of amphibian species (22.5%) compared to birds (0.8%), or mammals (5.3%) were 
considered data deficient, meaning not enough information was known about them to assign an 
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extinction threat category (Stuart et al., 2004). The causes of worldwide amphibian declines 
include habitat loss and degradation, environmental contamination, invasive species, emerging 
diseases, climate change, and overexploitation (Carey et al., 1999; Hocking and Babbitt, 2014). 
There is not likely to be a single cause for amphibian population declines, but rather a 
combination of factors. One proposed mechanism of globally occurring amphibian declines 
involves direct or indirect immunosuppression or immunomodulation by anthropogenic 
contaminants that would prevent the immune system from developing an adequate immune 
response against pathogen infection (Carey et al., 1999; Daszak et al., 1999). Amphibians are 
considered sensitive bioindicators of ecosystem health and, because of this, declining amphibian 
populations throughout the world and increasing rates of decline are potentially indicative of a 
much larger problem within our aquatic systems (Carey et al., 1999). 
1.3.2 Amphibian immunity and disease  
The two main components of the amphibian immune system are considered 
fundamentally similar to that of humans and immune defence mechanisms, in particular the 
molecules and cells involved in the innate response, maintain their functionality throughout 
vertebrates (Carey et al., 1999; Chen and Robert, 2011; Du Pasquier et al., 1989; Riera Romo et 
al., 2016). Resistance to pathogens encountered in the environment involves aspects of both the 
innate and adaptive immune responses in amphibian species. The innate immune system 
provides rapid and non-specific protection until the adaptive immune response has time to 
develop (Grogan et al., 2018). The innate immune response is of critical importance during larval 
life stages of the amphibian, a time when tadpoles are free swimming, developing externally, and 
confined to aquatic systems where contaminants and pathogens may be present concurrently. 
During the unique transitional life stage of metamorphosis, the immune system undergoes a 
substantial reorganization that includes, for example, a sharp decrease in lymphocyte populations 
and physical transformation of immune-related organs including the thymus and spleen (Du 
Pasquier et al., 1989; Rollins-Smith, 1998).This period of reorganization is accompanied by 
immunosuppression that persists for up to six months post-metamorphosis (Grogan et al., 2018). 
Effector cells of innate immunity that play vital roles in all amphibian species include 
leukocytes, macrophages, and natural killer type cells (Chen and Robert, 2011; Grogan et al., 
2018). The actions of many of these classes of effector cells are mediated by the release of 
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signaling molecules known as pro-inflammatory cytokines (Chen and Robert, 2011). The role of 
the innate immune response does not end with metamorphic climax. In fact, the innate immune 
system continues to play a critical role into adulthood in initiation of adaptive responses to 
specific foreign antigens (Grogan et al., 2018; Robert and Ohta, 2009). The adaptive immune 
response requires time to be activated after exposure to a pathogen and provides a specific 
response to pathogen infection together with the formation of memory cells, which respond 
rapidly and specifically to subsequent pathogen exposure (Carey et al., 1999). The amphibian 
adaptive immune response is relatively slow to manifest, and responds with lesser magnitude and 
efficiency than that of mammals (Grogan et al., 2018). During early life stages and into 
metamorphosis, the tadpole immune response is competent but functionally less developed than 
in post-metamorphic amphibians. A study by Sifkarovski et al. (2014) highlights the impacts of 
compromised immune system during critical developmental stages on immune function in post-
metamorphic amphibians. Following exposure to atrazine, a common herbicide, during 
metamorphosis (and even after a recovery period in clean water), researchers found that adult 
frogs displayed a persistent impaired ability to mount certain inflammatory responses to 
Ranavirus infection (Sifkarovski et al., 2014). 
1.4 Integrating transcriptomics with adverse effects of chlorpyrifos in amphibians 
 Integrating ‘omics technologies into the field of ecotoxicology has been a topic of much 
discussion in recent years as these technologies provide the unprecedented opportunity to  link 
adverse outcomes of chemical exposure to a specific molecular perturbation pattern in an 
increasingly reliable and high-throughput manner (Zhang et al., 2018). The transcriptome is 
defined as the ‘complete complement of mRNA molecules generated by a cell or population of 
cells’ (Piétu et al., 1999). Looking at the transcriptome of an individual gives information on 
which genes are expressed in that individual and at what level (McGettigan, 2013). In the context 
of ecotoxicology, transcriptomic data can be utilized to determine which genes are differentially 
expressed in response to chemical exposure in both field and laboratory scenarios (Feswick et al., 
2017). A list of these differentially expressed genes (DEGs) can then be mapped to biological 
pathways and processes to examine mechanisms of toxicity which, without this big data, would 
not be easily identifiable. When transcriptomic outcomes are integrated with other ‘omic 
approaches within a systems biology framework, apical outcomes of exposure can be anchored 
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to molecular and cellular level responses, and better define the mechanism of action of specific 
chemicals (Basu et al., 2019; Kavlock et al., 2018). With the recent development and 
increasingly widespread adoption of RNA-Seq technologies based on next generation sequencing 
platforms, transcriptomic data can be used to evaluate chemicals for their ability to alter key 
molecular pathways that precede phenotypic adverse outcomes of chemical exposure. Thus, 
toxicogenomics, the combination of toxicology and genomics technologies, also shows great 
promise as an early screening tool to prioritize chemicals with potential risk for adverse effects.  
In amphibians, there is a relative lack of mechanistic data regarding the toxicity of many 
contaminants of concern, including CPF. If predictive of apical outcomes, the larval 
transcriptomic profile has the potential to be employed as a rapid screening approach to assess 
the large number of contaminants threatening amphibian species globally. In addition, 
transcriptomic profiling after short-term, larval exposure has the potential to direct research into 
relevant outcomes of exposure to specific contaminants. To date, reference genomes for three 
anuran amphibian species, Xenopus tropicalis (Hellsten et al., 2010), Nanorana parkeri (Sun et 
al., 2015), and X. laevis (Session et al., 2016), have been published. 
 Studies in aquatic vertebrates other than amphibians have identified a number of gene 
pathways across a range of physiological processes and functions that respond to CPF exposure. 
Examining the transcriptome of the ciliate Uronema marinum following CPF exposure revealed 
changes in pathways related to cellular and metabolic processes, binding functions, and catalytic 
activities (Wang et al., 2018). Zhang et al. (2017) reported significant effects on the head kidney 
transcriptome of common carp exposed to CPF, specifically pathways involved in antioxidant 
systems and immune response as well as targeted effects on cytokine activity, oxidoreductase 
activity, and cell growth and death among others. Similarly, transcriptome and metabolome level 
analyses revealed that CPF exposure modulated pathways related to oxidative stress, energy and 
lipid metabolism, endocrine function, and proteolysis in Atlantic salmon hepatocytes (Olsvik et 
al., 2015). To date, there have been no studies examining CPF-mediated effects on the 
transcriptome of any amphibian species. However, in one study, exposure of Rana chensinensi to 
the OP pesticide trichlorfon led to significant transcriptome-level effects on cellular and 
metabolic processes, binding functions, and catalytic activities in the liver (Ma et al., 2018). Due 
to the widespread usage of CPF coupled with increased disease incidence and population 
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declines of some amphibian species, further research into the adverse effects and underlying 
mechanisms of CPF-mediated toxicity in amphibians is warranted. 
1.5 Project rationale 
There is limited data on the consequences of exposure to sub-lethal, environmentally 
relevant levels of CPF in amphibian species. Studies performed on fish species and other aquatic 
vertebrates are not always protective of sensitive amphibian species, especially when considering 
exposure during critical stages of development such as metamorphosis. To our knowledge, there 
is no literature regarding transcriptomic responses in amphibians after exposure to CPF. 
Additionally, there is no literature on the immune-related effects of short-term, sub-lethal 
exposure of amphibian species to CPF. For these reasons, and in the context of globally 
declining amphibian populations, it is important to address the lack of information currently 
available on the exposure of amphibian species to this common environmental contaminant.  
The overall goal of this thesis research was to gain a better understanding of the effects of 
CPF exposure on amphibians and provide much needed data on responses across levels of 
biological organization, from transcriptome to whole animal. Research was first focused on 
evaluating adverse outcomes of chronic exposure to CPF and linking key molecular response 
patterns that may be altered during exposure to CPF to these outcomes. I then focused 
specifically on effects of short-term CPF exposure on immune parameters and the ability of 
amphibians to respond to immune stimulation. Studies were conducted with the laboratory model 
amphibian X. laevis because (1) of the abundance of publicly available information including a 
fully sequenced genome (Session et al., 2016) and standardized exposure protocols throughout 
life stages, (2) it has been used as a model for studies of immunity (Robert and Ohta, 2009) as 
well as of immunotoxicity (De Jesús Andino et al., 2017; Sifkarovski et al., 2014) in amphibians, 
(3) hormone-induced breeding can provide embryos year-round, and (4) the time it takes for 
development from early larval stages to metamorphic climax and early juvenile life stage is 
relatively short. The aim of this research was to investigate the effects on development, health, 
and immune status of X. laevis after exposure to the common and ubiquitous environmental 
contaminant, CPF. The first study (Chapter 2) assessed transcriptome level changes in larval X. 
laevis after acute (96 h) exposure to environmentally relevant concentrations of CPF. These 
transcriptional changes were then compared to apical outcomes observed after chronic exposure 
16 
 
throughout early life stages. The second study (Chapter 3) measured contaminant-induced 
changes in the immune system of juvenile amphibians, and ultimately the impacts on 
immunocompetence and ability to mount an appropriate immune response when challenged with 
a known immunostimulatory agent. 
1.6 Research objectives and hypotheses  
The overall objective of this thesis research was to characterize the sub-lethal toxicity of 
CPF in amphibians by first identifying biological pathways that are altered with acute exposure 
to CPF and relating these transcriptional changes to higher-level responses in following chronic 
exposure. This information was then used to inform a particular target system (i.e. immune 
system) and relevant endpoints for a more detailed assessment of CPF impacts on immune 
response in amphibians.  
Chapter-specific objectives: 
1. Determine if acute (96 h) exposure to CPF during embryo-larval life stage of  X. laevis alters 
transcriptional response compared to unexposed individuals (Chapter 2) 
 H0: There are no differences in transcriptomic responses of larval X. laevis exposed to 
CPF compared to the control group 
 
2. Determine if chronic exposure (embryo to metamorphic climax) to CPF affects apical 
outcomes in X. laevis such as growth, development traits, incidence of deformities, liver 
histopathology, or AChE activity (Chapter 2) 
H0: CPF exposure has no effect on growth, development, liver histopathology, or AChE 
activity in X. laevis when exposed from embryo to metamorphic climax. 
 
3. Determine if short-term (7 d) exposure to CPF results in immunomodulation in juvenile X. 
laevis as measured by differential leukocyte counts, changes in pro-inflammatory cytokine 
expression, and histopathology of immune organs (Chapter 3) 
H0: Exposure to CPF for 7 days does not alter basal levels of circulating leukocytes, 
expression of pro-inflammatory cytokines, or histopathology of immune organs in 




4. Determine if CPF exposure alters the ability of X. laevis to mount a response to the 
immunostimulatory agent, lipopolysaccharide (LPS) (Chapter 3) 
H0: Exposure to CPF for 7 days does not alter the response of juvenile X. laevis 







INTEGRATING EARLY LIFE STAGE TRANSCRIPTOME ANALYSIS WITH APICAL 





This study assessed the toxicity of an emerging aquatic contaminant of concern, 
chlorpyrifos, in the model amphibian species Xenopus laevis. Transcriptomic responses were 
evaluated after 96 hour early life-stage exposure in an attempt to integrate observed 
transcriptomic changes with adverse outcomes in metamorphic individuals following chronic 
exposure to CPF. This chapter is organized as a manuscript for publication in a peer-reviewed 
scientific journal. Author contributions are as follows: 
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and exposures, collected and analysed the data and drafted the manuscript.  
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and edits to the manuscript, and obtained funding for the project.  
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Chlorpyrifos (CPF) is one of the most widely used organophosphate pesticides 
worldwide with extensive occurrence in aquatic ecosystems. Exposure to CPF is associated with 
adverse effects across a wide range of physiological parameters in fish, most notably 
neurotoxicity through inhibition of the enzyme acetylcholinesterase (AChE). However, effects of 
exposure to CPF in amphibians are relatively poorly studied with little information on the 
underlying molecular toxicity pathways associated adverse outcomes. The main objective of this 
study was to identify key molecular response patterns that are altered in amphibians with early 
life stage exposure to CPF, which may enable prediction of apical outcomes of ecological 
relevance in amphibians. The model amphibian, Xenopus laevis was exposed to CPF (0.4, 2, 10 
μg L-1, nominal) from 24 hours (h) post-hatch through to metamorphosis (50-55 days post-
hatch). Individuals were subsampled after 96 h and whole-body transcriptome profiles were 
assessed using high throughput sequencing (RNA-Seq). Pathway analysis revealed a number of 
significant dysregulated pathways including those associated with “classic” outcomes of CPF 
exposure, such as serine hydrolase activity (AChE is a serine hydrolase enzyme) and immune 
pathways, including immune function, inflammatory response, and cytokine receptor activity. 
Other affected pathways not typically linked to CPF were altered including vasculature 
development, sensory perception of light stimulus, and blood coagulation. Tadpoles exposed to 
CPF through to metamorphosis exhibited increased relative liver weight (30% increase in 10 μg 
L-1 treatment) and a dose-dependent decreased in brain AChE activity. Disruption of pathways 
associated with serine hydrolase following CPF exposure during early life stages is in agreement 
with decreased AChE activity at metamorphosis. Transcriptomic analysis also revealed a number 
of novel dysregulated pathways that could not be directly linked to apical outcomes measured in 
this study but suggests that CPF impacts a wide range of biological pathways in amphibians that 









 Amphibian populations have been declining in locations worldwide since the 1980s with 
declines being first recognized as a global issue in the early 1990s (Blaustein, 1994; Carey et al., 
1999; Hayes et al., 2010). Many hypotheses have been presented regarding the underlying 
factors driving dwindling amphibian populations including habitat loss and degradation, 
environmental contamination, invasive species, emerging diseases, climate change, and 
overexploitation (Carey et al., 1999; Hocking and Babbitt, 2014) although there is not likely to 
be a single driving factor for these declines. Either alone, or in combination with other 
environmental factors, agricultural pesticide use has been cited as a potential contributor to 
global amphibian declines and localized mass mortality events (Carey and Bryant, 1995; Hayes 
et al., 2006; Mann et al., 2009; Mason et al., 2013; Pounds and Crump, 1994).  
 Chlorpyrifos (CPF; C9H11Cl3NO3PS) is one of the most commonly used organophosphate 
(OP) pesticides throughout North America and worldwide (Adeyinka and Pierre, 2019). It is 
found ubiquitously within aquatic systems both in agriculturally intense areas and seemingly 
pristine locations far from anthropogenic sources (Muir et al., 2004; Zhang et al., 2012). In fact, 
samples taken from remote places including snow from Alaskan arctic estuaries and sea-ice from 
the Bering Sea have reported measurable CPF concentrations (Muir et al., 2004). Chlorpyrifos 
inhibits acetylcholinesterase (AChE), the enzyme responsible for hydrolysis of the 
neurotransmitter acetylcholine (ACh) in cholinergic synapses at neuromuscular junctions 
(Fukuto, 1990). In target species, this inhibition results in the desired toxic effects where ACh 
build up at neuromuscular junctions leads to loss of respiratory control and death by asphyxiation 
(Costa, 2006; Sparling and Fellers, 2007). However, AChE and the action of ACh are conserved 
across species and, as such, CPF exposure has the potential to cause toxicity in non-target 
species (Costa, 2006).  
 The World Health Organization (WHO) has classified CPF as R50/53 indicating that it is 
very toxic to aquatic animals with the potential to cause long-term adverse effects in aquatic 
ecosystems (WHO, 2015). Reported sub-lethal effects in aquatic vertebrates exposed to CPF 
include developmental delays and increased incidence of malformation (Jin et al., 2015; Kienle 
et al., 2009; Richards and Kendall, 2003), histological abnormalities across a range of tissues 
(Colombo et al., 2005; Kunjamma et al., 2008; Scheil et al., 2009; Xing et al., 2012), inhibition 
of AChE activity (Colombo et al., 2005; Jin et al., 2015; Liendro et al., 2015; Richards and 
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Kendall, 2002), immunomodulation (Adel et al., 2017; Jin et al., 2015; Kerby and Storfer, 2009; 
Maharajan et al., 2017), as well as changes at the molecular level, including changes in 
expression of specific genes and global transcriptome profiles in fish  (Wang et al., 2018; Zhang 
et al., 2017).  
In a recent comprehensive review of the available CPF literature that included an 
assessment of risk to aquatic organisms, the authors noted that there were few amphibian species 
with toxicity data for CPF (total of seven) and only three studies that met their criteria, which 
included data transparency and description of experimental procedures, among others (Giddings 
et al., 2014).  For these reasons, the authors did not consider amphibians further in the risk 
assessment (Giddings et al., 2014). Indeed, amphibian species are often overlooked and 
underrepresented in toxicity studies despite the vital and unique roles they play in aquatic 
ecosystems. Weltje et al. (2013) reviewed and compared acute and chronic toxicity data between 
fish and amphibians and concluded that larval stages of amphibians are less sensitive than fish to 
a range of chemicals, and thus, the toxicity data for fish can be extrapolated to and be protective 
of amphibians. However, a study by Watson et al. (2014) assessed morphological and 
physiological abnormalities in both zebrafish (Danio rerio) and Xenopus laevis larvae after CPF 
exposure and concluded that the amphibian species was more sensitive than zebrafish as it 
displayed by decreased heart rate and increased incidence of morphological abnormalities at 
lower concentrations of CPF (Watson et al., 2014). Cholinesterase-inhibiting pesticides have also 
been correlated with a decline of amphibian species in California, a state with very intense 
pesticide use (Davidson, 2004). Early life-stage (ELS) amphibians and tadpoles are free-
swimming, confined to aquatic systems where pesticides may be present, and lack fully 
functional detoxification pathways (Blaustein and Kiesecker, 2002; Ortiz-Santaliestra et al., 
2006). Additionally, amphibian metamorphosis includes a substantial reorganization of nearly 
every physiological system which can be accompanied by increased sensitivity to chemical and 
biological stressors in their environment (Grogan et al., 2018). This unique transitional life-stage 
is often not considered when extrapolating data from other aquatic vertebrates or when 
examining outcomes of exposure in acute exposure scenarios. 
The integration of ‘omics technologies into the field of ecotoxicology has been 
increasingly adopted in recent years due to the potential use of these technologies in both 
qualitative and quantitative measurement of changes from the molecular all the way to the 
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community level (Zhang et al., 2018). In the context of ecotoxicology, transcriptomic profiling 
can be used to determine which genes are differentially expressed in response to exposure to a 
contaminant (Feswick et al., 2017). This information can then be used to more clearly define 
previously unknown mechanisms of action of these contaminants of concern, such as CPF. These 
early toxicity pathways can be utilized to direct future research and inform on potential apical 
outcomes of relevance. Studies examining alterations in the transcriptomic profiles of aquatic 
vertebrates have identified a number of toxicity pathways across a wide range of physiological 
processes and functions after exposure to CPF. A study using the ciliate Uronema marinum 
reported effects on cellular and metabolic processes, binding functions, and catalytic activities as 
a result of CPF exposure (Wang et al., 2018). Another recent study by Zhang et al. (2017) 
reported alterations in the head kidney transcriptome of common carp (Cyprinus carpio) 
following exposure to CPF and included changes in transcripts related to cytokine activity, 
oxidoreductase activity, and cell growth and death among others. Similarly, Olsvik et al. (2015) 
reported effects on oxidative stress pathways, energy and lipid metabolism, endocrine function, 
and proteolysis in Atlantic salmon (Salmo salar) hepatocytes after exposure to CPF. To our 
knowledge, there have been no studies examining the effects of CPF exposure on the 
transcriptome of any amphibian species. 
 Despite the widespread use of CPF and its well-defined toxicity to fish species, there is a 
lack of amphibian data at multiple levels of biological organization regarding the outcomes of 
exposure to this ubiquitous aquatic contaminant. Therefore, the objectives of this study were to 
characterise the short-term, ELS transcriptomic response in X. laevis exposed to CPF and then 
identify effects of chronic exposure to sub-lethal levels of CPF from early life-stages to 
metamorphic climax. Differentially expressed genes were then identified and pathway analyses 
conducted in an attempt to establish key toxicity pathways for CPF in X. laevis and to determine 
if apical endpoints could be linked to CPF-induced changes at the molecular level. 
2.3 Materials and methods 
2.3.1 Obtaining Xenopus laevis embryos for exposures 
An adult X. laevis colony was maintained at a 12 hours (h) light:12 h dark photoperiod at 
16 ± 1 °C in the Aquatic Toxicology Research Facility at the Toxicology Centre, University of 
23 
 
Saskatchewan, Saskatoon, SK. Four sexually mature males and females were selected for 
breeding. Each was injected in the dorsal lymph sac with a 25 international unit (IU) priming 
dose of human chorionic gonadotropin (hCG, Sigma-Aldrich, St. Louis, MN, United States) 
dissolved in sterilized phosphate buffered saline (PBS;137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4). After priming injections, males and females were housed in 
separate aquaria at 21 ± l °C overnight. A second dose of hCG was administered approximately 
24 h after priming injections; males received a 250 IU dose and females received a 500 IU dose. 
Males and females were then randomly paired for breeding, placed into aquaria with water 
temperature maintained at 21 ± 1 °C, and left to spawn overnight.  
After collection, selection and preparation of embryos followed protocols outlined in 
“Standard guide for conducting the Frog Embryo Teratogenesis Assay-Xenopus (FETAX)” 
(ASTM, 2012). A maximum of 50 normally cleaving embryos were placed in individual egg 
cups, a vertical PVC pipe with two holes cut below a 100 μm Teflon mesh insert, to incubate in 
facility water maintained at 22 ± 1 °C for 24 h. After this incubation period, individuals were 
moved into petri dishes to begin the 96 h exposure period. Animals used in this study were 
handled in accordance with the University of Saskatchewan’s Animal Research Ethics Board 
(protocol #20160090) and adhered to the Canadian Council on Animal Care guidelines for 
humane animal use. 
2.3.2 Test chemical preparation  
Chlorpyrifos powder (CAS: 2921-88-2, purity: 98%) was purchased from TRC Canada 
(North York, ON, Canada). A CPF stock solution (1 mg ml−1) was prepared by dissolving the 
powder in dimethyl sulfoxide (DMSO) in a 100 ml glass bottle and stored at -4 ºC. Working 
stock solutions (4, 20, and 100 µg L−1) for each CPF exposure concentration were prepared in 
250 mL glass bottles and stored at 4 ºC. Facility water control and 0.01% v/v DMSO solvent 
control treatments were included and nominal CPF exposure concentrations for both the 96 h and 
chronic exposure were 0.4, 2.0 and 10 µg L−1 CPF. 
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2.3.3 CPF exposures and sampling 
2.3.3.1 96 h early life-stage exposure 
Exposures were initiated when the collected embryos reached approximately Nieuwkoop 
and Faber (NF) stage 29 (Nieuwkoop and Faber, 1994). Individuals were transferred into 50 mL 
glass petri dishes (30 individuals per petri dish; 10 petri dishes per treatment). Mortality, 
malformation, and abnormal behaviour were recorded and dead individuals were removed daily. 
A 50% water renewal was performed daily during the exposure period. Subsampling for 
transcriptomics was performed at the completion of the 96 h exposure when individuals (NF 
stage 46) were collected, pooled in groups of five, weighed, and flash frozen in liquid nitrogen 
and stored at -80 ºC.  
2.3.3.2 Long-term exposure through to metamorphic climax 
After the 96 h subsampling was complete, remaining individuals were transferred into 7 
L glass aquaria for the beginning of the chronic exposure period (30 individuals per tank; five 
tanks per treatment). During the chronic exposure 50 – 75% water changes were performed on 
each tank daily and mortality, malformation, and abnormal behaviour were recorded. 
Temperature was monitored daily and pH, dissolved oxygen, ammonia, nitrate, nitrite, hardness, 
alkalinity, and conductivity was monitored weekly for each tank (Appendix A). The chronic 
exposure was terminated at 75 days (d). Sampling occurred over five days, with one replicate 
tank per treatment sampled each day. Individuals were anesthetized by immersion in buffered 
0.1% tricaine methanesulfonate (MS-222) and euthanized by cervical dislocation. Morphometric 
endpoints including NF stage, wet body weight (to the nearest 0.01 g), snout-vent length (SVL; 
to the nearest 0.01 cm), total length (to the nearest 0.01 cm), and liver weight (to the nearest 0.01 
g) were measured and recorded for each individual. Brains from five individuals per tank were 
excised and flash frozen in liquid nitrogen before being stored at -80 ºC. A total of 25 whole-
body individuals per treatment (five from each replicate tank) were submerged in CalEx-II 
(Fisher Scientific) for 48 h to fix and decalcify and then transferred to 70% ethanol for storage. 
2.3.4 Analysis of CPF exposure concentrations 
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 Water samples were collected from exposure tanks at five specific times over the 
exposure period and sent to SGS AXYS (Sidney, BC, Canada) for analyses of actual waterborne 
CPF concentrations. A 47 mm all glass vacuum filter holder (Wheaton, Millville, NJ, United 
States) and a 90 mm Macherey-Nagel glass fiber filter (Fisher Scientific, Hampton, NH, United 
States) were used for filtration of samples. 200 mL of water was collected from each tank (5 
tanks/treatment) and poured into a 300 mL filtering cup where it passed through the glass fiber 
filter into a 1000 mL conical collection flask. The resultant 1 L composite sample was then 
transferred into a 1 L amber bottle for storage and shipment. An eyedropper was used to add 2 
drops of chloroform to each composite sample. Samples were stored at 4 ºC for no longer than 5 
days prior to shipment to SGS AXYS. Four time periods (exposure day 6, 40, 54, 75) throughout 
the chronic exposure period were selected for analysis of actual CPF concentrations. CPF 
concentrations were measured in each sample using high-resolution mass spectrometry.  
2.3.5 RNA extraction and Illumina sequencing   
Pooled, whole body NF stage 46 individuals were used for the transcriptomic analysis 
after 96 h exposure to CPF. RNA was extracted from five replicates each containing five 
individuals from three treatment groups: 0.01% DMSO solvent control, 2 μg L−1and 10 μg L−1 
CPF. Total mRNA was obtained using the QIAcube and the RNeasy Plus Universal Mini kit as 
directed by the manufacturer (Qiagen, Hilden, Germany). RNA concentration was measured 
using the QIAxpert (Qiagen). RNA integrity was assessed using the Bioanalyzer 2100 and 
associated RNA Nano 6000 Assay kit (Agilent Technologies, CA, USA). Samples with a 
minimum RNA Integrity Number of 7.0 were used for transcriptomic analysis. Samples were 
diluted using sterile RNAse-free water to a final volume and concentration of 25 µL of 100 ng 
µL-1 RNA and stored at -80 ºC until sequencing. 
Transcriptome sequencing was performed at Genome Quebec Innovation Center (McGill 
University, Montreal, QC, Canada). Briefly, libraries of double-stranded DNA from total RNA 
were prepared using the Illumina TruSeq Stranded mRNA library prep kit (Illumina Inc., San 
Diego, CA, United States). Size selection of DNA fragments was performed using solid phase 
reversible immobilization beads. Quality of libraries were confirmed using the Bioanalyzer 2100 
and associated DNA 1000 Nano Assay kit (Agilent Technologies). Libraries were multiplexed 
with TruSeq RNA Single Index kits and loaded onto HiSeq 3000/4000 PE Cluster kit for cluster 
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generation (Illumina Inc.). Clusters were loaded onto a HiSeq 4000 Sequence-by-Synthesis kit 
and run as 100 base pair paired-end reads over 200 cycles using a HiSeq 4000 system (Illumina 
Inc.). 
2.3.6 Liver histology  
Histological analysis of liver tissue was performed on NF stage 65 individuals from the 
chronic exposure. Twenty individuals, ten each from the solvent control and the 10 µg L−1 CPF 
treatment groups, were randomly selected for histological analysis. Carcasses were trimmed to 
remove the limbs and head, and the body wall was cut away to fully expose the viscera. Each 
sample was then placed into a tissue embedding histocassette and rinsed twice with 70% ethanol 
to remove traces of fixative. Tissues were processed using a RVG1 vacuum tissue processor 
(Intelsint S.R.L., Villarbasse, TO, Italy). After processing, whole-body tissues were embedded in 
paraffin wax. Each sample was longitudinally step-sectioned at a thickness of 5 µm, mounted on 
slides, and dried at 37 °C for approximately 12 h. For each individual, two consecutive sections 
were taken at a minimum of 11 different levels at 50 μm intervals. Sections were stained with 
regressive hematoxylin and eosin and examined using an Axiostar Plus microscope (Carl Zeiss 
Microscopy, Thornwood, NY, United States). Photographs of each slide were taken using an 
attached INFINITY1-1M digital camera, and associated Infinity Analyze software (Lumenera 
Corporation, Ottawa, ON, Canada). Liver sections were screened qualitatively for signs of 
hepatoxicity and each individual was scored (0=absent; 1=mild; 2=moderate; 3=severe) for 
degree of hepatocyte vacuolization, incidence of hepatocyte necrosis, number and size of 
melanomacrophages, and degree of sinusoid dilation.  
2.3.7 Acetylcholinesterease activity assay 
Acetylcholinesterase activity in brain was measured using the Acetylcholinesterase 
Activity Assay kit (MAK119) in accordance with the manufacturer protocols (Sigma-Aldrich, St. 
Louis, MN, United States). Tissues were homogenized in 0.1 M phosphate buffer at pH 7.5 (75.4 
mM H15Na2O11P, 24.6 mM H4NaO5P) using a PowerGen 125 tissue homogenizer (Fisher 
Scientific, Hampton, NH, United States). Samples were then centrifuged at 14 000 rpm for 5 min 
at room temperature and the supernatant was collected to be used for the assay. Six brains from 
the 0.01% DMSO, and each CPF treatment group were analyzed in duplicate. A SpectraMax 
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microplate reader at 412 nm wavelength was used to determine the AChE activity of each 
sample (Molecular Devices LLC, San Jose, CA, United States). Data are presented as Units 
AChE per g tissue where units AChE is equal to μmol substrate hydrolyzed per minute. 
2.3.8 Transcriptomic data preparation and statistical analysis 
 RNA-Seq reads were uploaded to the Galaxy platform https://usegalaxy.eu/ (Afgan et al., 
2018). Quality control checks were performed using FastQC (Andrews, 2010) and two of the 2 ug 
L-1 CPF samples were found to have low per base sequence quality. Further analysis continued 
with the solvent control and 10 ug L-1 CPF concentration samples. Poor quality sequences were 
trimmed using the Trimmomatic tool (Bolger et al., 2014) with a phred quality score of 28 and a 
minimum sequence length of 35. Reads were mapped using HISAT2 (Kim et al., 2015) to the X. 
laevis reference genome (GCF_001663975.1) available online at the National Center for 
Biotechnology Information website (https://www.ncbi.nlm.nih.gov/). SAMtools sort (Wysoker et 
al., 2009) was then used to sort the resultant alignments by read name. Finally, ht-seq count 
(Anders et al., 2015) was used to count the number of reads mapped to each gene feature.  
 Counts data to be used for gene-level differential expression analysis was then uploaded 
into EcoToxXplorer (https://www.ecotoxxplorer.ca). The edgeR tool built into the 
EcoToxXplorer platform was utilized for differential gene expression analysis (Robinson et al., 
2009). The solvent control treatment was used as a common control and genes were considered 
significantly differentially expressed at false discovery rate (FDR) = 0.1. The ClueGo (v 2.5.3; 
Bindea et al., 2009) plugin on Cytoscape was used to identify functionally grouped networks 
(Shannon et al., 2003). ClueGo visualization of functional networks formed from significantly 
dysregulated pathways were based on Gene Ontology (GO) vocabularies biological processes, 
molecular functions, and cellular components (accessed on: 13/03/2019). Pathways were built 
using at least 5 genes from the differentially expressed genes (DEGs) after 96 h ELS exposure to 
10 ug L-1 CPF (p ≤ 0.05). Statistical test was set to a right-sided hypergeometrical test with a 
Bonferroni (step down) p-value correction and a kappa score of 0.4.  
2.3.9 Statistical analysis 
Data obtained from apical endpoints measured were tested for a normal distribution using 
the Shapiro-Wilk test and for homoscedasticity using Levene’s test. In cases where the 
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assumption of normality was violated, data was analyzed using the non-parametric Kruskal-
Wallis H test (p ≤ 0.05). This was followed by pairwise comparisons using Dunn’s procedure 
with a Bonferroni correction for multiple comparisons. When the assumptions of normality and 
homoscedasticity were met, data was analyzed using a one-way analysis of variance (ANOVA). 
Post-hoc tests (either Tukey’s HSD or an LSD test) were employed in cases where ANOVA 
revealed a significant difference between groups (p ≤ 0.05). Hypothesis testing was two-tailed. 
All analyses were conducted using SPSS Statistics 25 (IBM Corporation, Armonk, NY, United 
States). 
2.4 Results 
2.4.1 Chemical analysis of CPF 
 Recovery of CPF was 17% in the 0.4 ug L-1 concentration group (0.066 ug L-1), 24% in 
the 2 ug L-1 concentration group (0.485 ug L-1), and 29% in the 10 ug L-1 concentration group 
(2.890 ug L-1) (Table 2.1).  From this point forward, the concentrations are referred to as “low”, 





Table 2.1. Nominal and actual concentrations of chlorpyrifos (CPF) throughout the chronic 





 CPF Concentration (μg L-1) 
0.01%  
DMSO 0.4 2 10 
 D6 0.0029 0.143 0.864 4.200 
 D40 0.0015 0.005 0.278 1.700 
 D54 0.0038 0.044 0.342 1.750 
 D75 0.0076 0.070 0.455 3.900 
Average   0.0039 0.066 0.485 2.890 
Percent of Nominal   17% 24% 29% 





2.4.2 Differentially expressed gene and pathway analysis 
Whole body transcriptome analysis examined 24205 genes total and revealed 50 DEGs 
after 96 h ELS exposure to the highest CPF concentration as compared to the solvent control 
(FDR = 0.1). Of these, 17 were upregulated and 33 were downregulated (Table 2.2). Key 
biological processes and pathways affected by CPF exposure were visualized as functional 
networks (Fig. 2.1) formed from significantly upregulated (Fig. 2.2) or depleted pathways (Fig. 
2.3). These pathways were based on GO terms related to biological processes, molecular 








Table 2.2. Differentially expressed genes in X. laevis after 96 h early life-stage exposure to chlorpyrifos. 
Gene ID log Fold Change Name 
LOC108699634 5.5981 RNA polymerase II degradation factor 1-like, transcript variant X3 
LOC108707016 4.6741 RING finger protein 212B-like 
LOC108697970 2.76 taste receptor type 2 member 9-like 
cyp2j2.L 1.4291 cytochrome P450 family 2 subfamily J member 2 L homeolog, transcript variant X1 
MGC84235 1.0533 MGC84235 protein 
LOC108716281 0.74148 fucolectin-4-like 
arr3.L 0.70224 arrestin 3, retinal (X-arrestin) L homeolog 
LOC108707450 0.53404 retinoschisin-like 
hsd3b7.S 0.51542 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 S homeolog, transcript variant X1 
masp2.S 0.39813 mannan-binding lectin serine peptidase 2 S homeolog, transcript variant X1 
LOC108701136 0.39432 alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1-like 
LOC108703002 0.34747 dual 3’,5’-cyclic-AMP and -GMP phosphodiesterase 11A-like 
LOC108714924 0.26441 mucin-5AC-like 
LOC108709438 0.14402 plakophilin-1-like 
LOC108704439 0.13438 E3 ubiquitin-protein ligase TRIM39-like 
xclca2 0.1117 calcium activated chloride channel 
LOC108702356 0.068711 up-regulator of cell proliferation-like 
LOC108711733 -0.04594 A.superbus venom factor 1-like 
LOC108702434 -0.13085 NADPH oxidase organizer 1-like 
MGC68455 -0.26697 Glucose-6-phosphatase-like 
LOC108698286 -0.30285 NADPH oxidase 1-like 
LOC108714562 -0.42 cytokine receptor common subunit beta-like 
c3.L -0.4549 complement component 3 L homeolog 
LOC108717079 -0.52738 ceruloplasmin-like 
LOC108715543 -0.54158 transmembrane protein 125-like 
LOC108710049 -0.61908 glycerophosphodiester phosphodiesterase domain-containing protein 5-like, transcript variant X1 
LOC398210.L -0.62757 uncharacterized LOC398210 L homeolog 
LOC494638 -0.68665 uncharacterized LOC494638, transcript variant X2 







LOC108697412 -0.70506 probable carboxypeptidase X1 
LOC108715761 -0.75516 protein FAM83F-like 
LOC108710292 -0.90759 dual oxidase 1-like 
LOC108719393 -1.3564 transient receptor potential cation channel subfamily V member 4-like 
LOC108713225 -1.5865 protein DVR-1-like 
LOC108719568 -1.786 thiosulfate sulfurtransferase-like 
LOC108696752 -1.8144 uncharacterized LOC108696752, transcript variant X2 
steap4.L -1.9427 STEAP4 metalloreductase L homeolog 
LOC108703485 -2.3044 nuclear factor interleukin-3-regulated protein-like 
LOC108708918 -2.3482 alpha-tectorin-like 
LOC108708107 -2.424 cell wall protein DAN4-like 
LOC108709478 -2.5071 uromodulin-like 
LOC100036845 -2.5134 uncharacterized LOC100036845 
LOC108708109 -2.5619 pancreatic secretory granule membrane major glycoprotein GP2-like 
LOC108706182 -2.6118 platelet glycoprotein Ib alpha chain-like 
LOC108701668 -2.6226 NADPH oxidase organizer 1-like 
thdl18.L -2.7757 thyroid hormone down-regulated protein (gene 18) L homeolog 
thdl20.S -2.7968 thyroid hormone down-regulated protein (gene 20) S homeolog 
LOC108709109 -2.851 uromodulin-like 








Figure 2.1. ClueGo visualization of functionally grouped networks formed from significantly 
dysregulated pathways based on Gene Ontology (GO) databases (13/03/2019). Pathways were 
built using at least five differentially expressed genes (p ≤ 0.05) in early life-stage X. laevis after 
96 h of chlorpyrifos exposure. Statistical test was set to a right-sided hypergeometrical test with a 
Bonferroni (step down) p-value correction and a kappa score of 0.4. Node size represents 
pathway significance and darker shades represent higher gene proportion associated with 
pathway. Green node = depleted pathway, gray node = un-specific pathway, red node = 
upregulated pathway. A list of all significantly dysregulated pathways as well as this figure with 






Figure 2.2. ClueGo output displaying pathways and biological processes associated with 
upregulated genes in X. laevis based on gene ontology (GO) vocabularies (13/03/2019) after 96 h 
early life-stage exposure to chlorpyrifos. (A) Networks formed from significantly upregulated 
pathways (p ≤ 0.05). Node size represents pathway upregulation significance. (B) Overview 
chart of functional groups including specific pathways associated with upregulated genes. The 
proportion of each group (%) is based on the number of GO terms included within each group. 
(C) Bar chart displaying the percentage of total genes (top) and number of differentially 







Statistically significantly upregulated GO terms are represented by: (***) = p ≤ 0.001, (**) = 






Figure 2.3. ClueGo output displaying pathways and biological processes associated with 
downregulated genes in X. laevis based on gene ontology (GO) vocabularies (13/03/2019) after 
96 h early life-stage exposure to chlorpyrifos. (A) Networks formed from significantly depleted 
pathways (p ≤ 0.05). Node size represents pathway depletion significance. (B)  Overview chart 
of functional groups including specific pathways associated with downregulated genes. The 
proportion of each group (%) is based on the number of GO terms included within each group. 
(C) Bar chart displaying the percentage of total genes (top) and number of differentially 
expressed genes (end of bar) associated with each GO term colour coded by pathway or function. 
Statistically significantly depleted GO terms are represented by: (***) = p ≤ 0.001, (**) = 0.001 








2.4.3 Morphometrics  
There was no effect of treatment on survival after chronic CPF exposure (ANOVA: F(4,24) 
= 0.525; p = 0.718). Overall survival in the water and solvent control treatments combined was 
95%.  No difference in SVL or wet body weight occurred after chronic exposure to CPF (Table 
2.3). There was a statistically significant decrease in NF stage in the medium CPF treatment as 
compared to the low CPF treatment (data not shown, Kruskal-Wallis: H(4)=9.963, p=0.041).  A 
significant decrease in the percentage of tadpoles that reached metamorphic climax, NF stage 65, 
occurred in the medium and high treatment groups compared to the water control (Table 2.3, 
ANOVA: F(2, 24) = 3.393, p = 0.028). Relative liver weight was 30% higher in individuals from 
the high CPF treatment group compared to the solvent control (Table 2.3, ANOVA: F(4,122) = 
2.862; p = 0.026). 
2.4.4 Effects of CPF on liver histology 
 Individuals from the solvent control group displayed a typical liver structure, comprised 
of hepatocytes arranged in cords 1-2 cells thick with sinusoids between cords containing 
erythrocytes. Qualitative screening for histopathological indicators of hepatotoxicity revealed no 
apparent differences in the structure of high CPF exposed livers as compared to the solvent 
control (Table 2.4).  
2.4.5 Effects of CPF on AChE activity 
 A concentration-dependent decrease in AChE activity was observed in brains of X. laevis 
at metamorphic climax following chronic exposure to CPF. Compared to the solvent control, 
median AChE activity was 2.1% lower in the low treatment group, 17.9% lower in the medium 
treatment group, and 24.0% lower in the high treatment group (Fig. 2.4). These differences were 





Table 2.3. Morphometric indices (mean ± SEM) including snout-vent length (SVL), wet body 
weight, relative liver weight, and % individuals at Nieuwkoop Faber stage 65 for X. laevis 
tadpoles exposed chronically to waterborne chlorpyrifos (CPF). 
 
Treatment SVL (mm) Wet Weight (g) 
Relative Liver 
Weight (mg g-1) 
% at  
NF stage 65 
Facility Water  15.74 ± 0.30 0.313 ± 0.019 0.0097 ± 0.0009 15a 
0.01% DMSO  15.86 ± 0.35 0.312 ± 0.020 0.0083 ± 0.0007 13ac 
0.4 μg L-1 CPF 14.97 ± 0.20 0.306 ± 0.018 0.0104 ± 0.0008 14a 
2 μg L-1 CPF 15.16 ± 0.24 0.340 ± 0.023 0.0089 ± 0.0007 5b 
10 μg L-1 CPF 15.47 ± 0.26 0.336 ± 0.021 0.0120 ± 0.0009* 7bc 
 
Asterisk (*) indicates significant difference from solvent control (ANOVA: F(4,122) = 2.862; p = 0.026). 
Letters indicate significant differences between groups (ANOVA: F(2, 24) = 3.393, p = 0.028) 







Table 2.4. Severity of histological parameters qualitatively examined in liver of X. laevis at 
metamorphic climax after chronic exposure to waterborne chlorpyrifos (CPF).  
-- = absent; + = mild, ++ = moderate; +++ = severe 
 
  






1 -- -- -- -- 
2 -- -- ++ + 
3 -- -- +++ + 
4 -- -- +++ -- 
5 -- -- ++ ++ 
6 -- -- + - 
7 -- -- +++ + 
8 -- -- + -- 
9 -- -- + -- 
10 -- + + ++ 
10 μg L-1 
CPF 
1 -- -- +++ -- 
2 ++ -- ++ -- 
3 -- -- ++ -- 
4 -- -- + -- 
5 -- -- +++ +++ 
6 -- -- ++ -- 
7 -- -- ++ ++ 
8 -- -- + -- 
9 -- -- +++ ++ 





Figure 2.4. Median (± IQR) brain acetylcholinesterase (AChE) activity in NF stage 57 – 64 X. 
laevis after chronic exposure to chlorpyrifos (CPF). Data is presented in Units AChE per g tissue 
where units is equal to μmol substrate hydrolyzed per minute. Asterisk (*) indicates significant 
differences between groups (Kruskal-Wallis: H(3) = 9.647, p = 0.022). 
  






























2.5 Discussion  
 In the present study, we analyzed the transcriptomic responses of X. laevis after 96 h of 
CPF exposure as well as apical outcomes of chronic CPF exposure on X. laevis at metamorphic 
climax. This was the first study to look at the short-term transcriptomic responses of ELS X. 
laevis after CPF exposure. Pathway analysis revealed impacts on the biological processes and 
molecular functions of ELS X. laevis after short-term exposure to environmentally relevant 
concentrations of CPF. Some of these significantly dysregulated pathways were associated with 
“classic” and well-documented outcomes of CPF exposure, such as serine hydrolase activity, and 
others were related to outcomes not generally associated with exposure to CPF or OP pesticides, 
such as altered vasculature development.  
2.5.1 Developmental processes affected by CPF exposure 
Pathways related to vasculature development (GO:0001944) were significantly depleted 
after 96 h exposure to CPF. Across vertebrate species, blood vessels are among the first organs to 
develop during embryogenesis (Carmeliet and Collen, 1998). Alterations of the developing 
vascular system in ELS organisms are associated with a range of pathologies from malformation 
and deformity to mortality (Katagiri, 1983; Zhong et al., 2018). However, evidence suggests that 
exposure to some compounds can cause vascular abnormalities without any external signs of 
malformation. In a study on zebrafish (D. rerio) embryos exposed to cadmium, Cheng et al. 
(2001) examined effects on development of the vasculature by injection of microbeads into the 
circulation and found vasculature defects which were not associated with any visible 
malformation. Components of the extracellular matrix, such as fibronectins and collagen, play a 
primary role in vasculature development (Carmeliet and Collen, 1998). In the present study, 
transcriptome profiling in ELS X. laevis revealed that the extracellular region (GO:0005576) was 
the most significantly impacted cellular component after 96 h CPF exposure. The extracellular 
region is specifically involved in the production of endothelial cells that line the vasculature. The 
impacts of CPF on the extracellular regions of cells, and the potential alteration of vasculature 
development as an outcome warrants further exploration. 
The depletion of pathways associated with vasculature development included effects on 




as OP pesticides, including CPF, are known cardiotoxic agents in aquatic animals including 
Carcinus maenas and Oreochromis niloticus even after acute exposure (Lundebye et al., 1997; 
Thomaz et al., 2009). However, the literature regarding the cardiotoxic effects of CPF in 
amphibians is relatively scarce. A study by Watson et al. (2014) reported a dose-dependent 
decrease in heart rate in larval X. laevis after 96 h exposure to environmentally relevant 
concentrations of CPF. In the present study, DEG analysis revealed the most significantly 
differentially expressed gene after 96 h of CPF exposure in ELS X. laevis was an upregulated 
cytochrome p450 (CYP) isoform, CYP-2J2. In humans and zebrafish (D. rerio), this gene is an 
arachidonic acid epoxygenase with vasoprotective roles in the cardiovascular system (Goldstone 
et al., 2010). If the function of this gene is conserved across species, upregulation of CYP-2J2 
agrees with the pathway analysis revealing cardiovascular effects of CPF exposure in early life 
stage tadpoles.  
Body size of metamorphic individuals was not affected by CPF after chronic exposure 
despite the fact that ELS exposure to CPF clearly altered transcriptomic profiles related to 
vasculature development and other developmental processes. Studies on amphibian species Rana 
dalmatina and Rana fernandezae reported no effect on amphibian body size after chronic 
exposure to CPF concentrations ranging from 10 – 500 μg L-1  (Bernabò et al., 2011; Ruiz de 
Arcaute et al., 2012). Similarly, Sparling and Fellers (2009) reported no difference in SVL after 
exposure to CPF concentrations as high as 200 μg L-1 and a significant decrease in body weight 
only in the 200 μg L-1 treatment group in Rana boylii after a 56 d exposure period. Dimitrie and 
Sparling (2014) reported dose-dependent decreases in SVL and body weight after exposure to 
CPF from larval stages through to metamorphosis in Pseudacris regilla. However, this exposure 
was conducted at nominal concentrations ranging from 134 – 294 μg L-1 CPF, which is 
approximately 44 – 98 times higher than our highest measured CPF concentration. In contrast, 
Jayawardena et al. (2011) reported a dose-dependent increase in SVL and body weight in Bufo 
melanostictus after chronic CPF exposure at concentrations ranging from 50 – 500 μg L-1. There 
was no increased incidence of malformations present in any CPF treatment group in this study. 
As with reported effects of CPF on body weight and SVL in across published studies, effects of 
CPF exposure on incidence of malformations is also highly variable across exposure 




In the present study, chronic exposure to CPF resulted in fewer individuals reaching NF 
stage 65 (metamorphic climax) at termination of the exposure. This finding is supported by a 
number of studies with amphibians that report increased time to metamorphosis after CPF 
exposure (Dimitrie and Sparling, 2014; Jayawardena et al., 2011; Sparling and Fellers, 2009).  
Exposure to CPF led to dysregulation of a number of pathways related to energy metabolism and 
various metabolic processes, which will be discussed in further detail in following sections. 
Disruption of these metabolic functions could be tied to the observed decrease in successful 
completion of metamorphosis as more energy is used to keep up with increased metabolic 
demand and less is available for the process of metamorphosis. The range of reported effects on 
morphometric indices in amphibian species after exposure to CPF highlights the importance of 
considering species differences in amphibian research. At our exposure concentrations, 
significant dysregulation of pathways specific to vasculature development and development of 
the cardiovascular system occurred after short-term exposure. This, combined with the lack of 
significant alteration of classic morphometric indices such as wet body weight and SVL after 
long-term exposure, suggests that future research into the developmental effects of CPF exposure 
in amphibians should consider morphological changes in the vasculature and cardiovascular 
system. 
2.5.2 CPF inhibits AChE and pathways associated with serine hydrolase activity  
One of the classic biomarkers of exposure to OP pesticides is inhibition of AChE, a 
serine hydrolase enzyme, and this is the mechanism of toxic action of CPF. Specifically, enzyme 
inhibition occurs when the serine hydroxyl moiety in the enzyme active site is phosphorylated 
leaving the enzyme unable to participate in the breakdown of ACh (Fukuto, 1990). Short-term 
exposure to CPF can inhibit AChE activity in amphibian species (including X. laevis) at 
concentrations as low as 8.87 μg L-1  (Colombo et al., 2005; El-Merhibi et al., 2004; Liendro et 
al., 2015; Wacksman et al., 2006; Widder and Bidwell, 2006). It is important to note, however, 
that these studies are limited in scope in that they use only short-term exposures with CPF 
concentrations higher than environmentally relevant and consider early larval life-stages only, 
despite evidence that metamorphs are more sensitive to AChE inhibition by CPF than 
premetamorphs (Richards and Kendall, 2002). The present study is the first to show that chronic 




brain of metamorphic X. laevis. This observed characteristic response to CPF also confirms 
waterborne CPF exposure in our experimental system, despite the fact that our analysed 
concentrations were 20% of our nominal concentrations. There was also a significant and non-
specific dysregulation in pathways associated with serine hydrolase activity after short-term 
exposure in ELS individuals. Acetylcholinesterase is a serine hydrolase enzyme. Thus, 
dysregulation of this pathway as indicated in the ELS transcriptome may be associated with the 
apical outcome of AChE inhibition in metamorphic individuals.  
2.5.3 CPF-induced changes in metabolic processes and liver weight 
 Pathways associated with metabolic processes were significantly upregulated in ELS X. 
laevis after 96 h exposure to CPF. These included pathways related to the regulation of 
proteolysis as well as biosynthesis of carbohydrates. Within the pathways associated with 
proteolysis and protein metabolism, negative regulation of proteolysis (GO: 0045861) was the 
most significantly upregulated. This indicates that CPF interfered with the frequency, rate, or 
extent of the hydrolysis of a peptide bond or bonds within a protein (MGI, 2019). A study by 
Olsvik et al. (2015) examined the transcriptomic and metabolomic profiles of Atlantic salmon (S. 
salar) after exposure to CPF and  reported a significant increase in multiple free amino acids in 
hepatocytes. They concluded that the accumulation of these compounds was indicative of a 
decrease in protein synthesis, or an increase in proteolysis (Olsvik et al., 2015). Other studies 
have reported significant activation of protease, a hydrolytic peptidase enzyme, after CPF 
exposure in rats and mice with the highest level of activation found within liver tissues (Muniya 
Naik et al., 2018; Savithri et al., 2016). This activation is indicative of altered protein metabolism 
and increased proteolysis. A number of GO terms in the present study that were related to 
protease activity were significantly upregulated including: peptidase regulator activity 
(GO:0061134), regulation of peptidase activity (GO:0052547), and negative regulation of 
hydrolase activity (GO:0051346). In addition to protein metabolism, CPF exposure in ELS X. 
laevis also altered carbohydrate metabolism with the most significantly upregulated pathway 
being the hexose biosynthetic process (GO:0019319). This indicates that CPF exposure 
interfered with the chemical reactions and pathways resulting in the formation of hexose (MGI, 
2019). Metabolomic profiles in Atlantic salmon (S. salar) liver after CPF exposure also revealed 




their metabolic pro- and pre-cursors (Olsvik et al., 2015). Although the present study analysed 
whole-body transcriptomic profile while the study by Olsvik et al. (2015) focused on fish 
hepatocytes specifically, similar pathways related to protein and carbohydrate metabolism and 
metabolic processes were affected, suggesting metabolic consequences of CPF exposure can be 
applied across taxa.  
The liver is a key metabolic organ across vertebrate species, including amphibians, and 
the site of many metabolic processes, such as carbohydrate and protein synthesis (Rui, 2014) 
(Akiyoshi and Inoue, 2012). Despite dysregulation of key metabolic pathways after the ELS 
exposure to CPF, there were limited apical effects of chronic CPF exposure in the liver of X. 
laevis at metamorphic climax. Relative liver weight was higher in individuals chronically 
exposed to the highest concentration of CPF. This could be associated with the observed 
dysregulation of metabolic processes at the early life stages, specifically upregulation of 
processes associated with proteolysis and carbohydrate biosynthesis, as hepatocytes expand to 
compensate for increased metabolic demand. Endpoints for qualitative histopathological 
assessment were selected to lend further insight into the impacts on metabolism and metabolic 
processes after CPF exposure. Qualitative histopathological assessment of liver tissue from 
metamorphic X. laevis revealed no obvious tissue-level effects of chronic CPF exposure despite 
overall increase in liver weight relative to body size and an upregulation of metabolic pathways 
in the transcriptome of ELS individuals.  
2.5.4 CPF exposure depletes pathways related to immune function and response 
 Exposure to CPF has been linked to immunosuppression and immunomodulation in fish 
following both short-term (Adel et al., 2017; Jin et al., 2015; Marchand et al., 2017) and long-
term (Ural, 2013; Wang et al., 2011, 2013; Zhang et al., 2017) exposures. A recent study 
examined transcriptomic profiles in C. carpio exposed to CPF and reported significant 
dysregulation in pathways related to immune response and immune system function (Zhang et 
al., 2017). In the present study, short-term exposure to CPF significantly affected pathways 
involved in immune function in ELS X. laevis. Gene ontology terms immune function 
(GO:0006955), inflammatory response (GO:0006954), and cytokine receptor activity 
(GO:0004896) were all significantly depleted after 96 h exposure to CPF. In the only other study 




(2009) reported a >60 % decrease in survival in tiger salamanders (Ambystoma tigrinum) when 
exposed concurrently to CPF and Ambystoma tigrinum virus as compared to individuals exposed 
to the same concentration of CPF alone. The depletion immune-related pathways after ELS 
exposure to CPF observed in our study provides some insight into which pathways are 
modulated by CPF, potentially leading to immunomodulation/immunosuppression and pathogen 
susceptibility. The present study did not measure apical endpoints associated with 
immunotoxicity after chronic CPF exposure; however, given the established immunotoxicity of 
CPF in fish species and the alteration of immune-related pathways in the ELS X. laevis 
transcriptome, further examination of the immunotoxic effects of CPF in amphibian species is 
warranted.    
2.5.5 ELS exposure to CPF modulates other biological pathways in X. laevis 
There were several other pathways dysregulated with ELS exposure to CPF and included 
pathways associated with blood coagulation, sensory perception of light stimulus, and molecular 
function and binding. Blood coagulation (GO:0007596) falls under the umbrella of response to 
stress (GO:0006950) and, more specifically, wound healing (GO:0042060), which is the series of 
events that restores integrity to damaged tissue following an injury (MGI, 2019). Blood 
coagulation is an integral part of the immune system, and is considered a sentinel for the immune 
response when considered in conjunction with activation of the complement system (Bougas et 
al., 2013). In fact, when visualized in Cytoscape the upregulated pathways involving blood 
coagulation were overlapping with the depleted pathways involving immune response, 
suggesting that the two responses are highly related. Dysregulation of blood coagulation 
pathways has been reported in a number of aquatic vertebrates after exposure to biological and 
contaminant stressors including Chytrid fungus in Xenopus tropicalis (Rosenblum et al., 2009) 
and heavy metals in Perca flavescens (Bougas et al., 2013). 
 There were two categories of significantly dysregulated GO terms related to molecular 
function in the present study – those to do with enzyme activity, which were both upregulated 
and depleted, and those associated with cellular binding, which were specifically upregulated. 
The most significantly upregulated GO term associated with binding was tetrapyrrole binding 
(GO:0046906). Tetrapyrrole binding is the parent term for heme binding, which was also 




covalent interaction with heme, any compound of iron complexed in a tetrapyrrole ring (MGI, 
2019). When taken up by an organism, CPF undergoes phase I biotransformation mediated by 
CYP monooxygenase enzymes to produce the oxon-analog, a more potent anticholinesterase 
(Fukuto 1990; Wacksman et al., 2006). In fact, the formation of the oxon-analog from CPF is 
essential to the mode of action as the parent compound itself is not considered to be a strong 
inhibitor of AChE (Solomon et al., 2014). More specifically, the mechanism of action involves 
an irreversible binding of CPF to the heme iron of CYP enzymes to produce the phosphate oxon 
active metabolite (Rajpoot et al., 2013). Monooxygenase activity (GO:0004497) was 
significantly upregulated in the same network as upregulation of tetrapyrrole binding after CPF 
exposure. From these results, it appears that in amphibians, as in other vertebrates, the 
mechanism of toxic action for CPF is mediated by phase I biotransformation enzymes. 
Another significantly upregulated pathway in ELS X. laevis after CPF exposure was sensory 
perception of light stimulus (GO:0050953), neurological process that falls under the umbrella of 
nervous system process (GO:0050877). The primary mechanism of toxic action of OP pesticides 
in general, including CPF, is neurotoxicity, as such, effects on the nervous system are an expected 
outcome of CPF exposure (Galloway and Handy, 2003). Altered swimming behaviour in response 
to stimulation of light to dark photoperiod transitions have been reported in zebrafish after 96 h 
exposure to CPF (Jin et al., 2015). There are no studies on behavioural responses to light stimulus 
following CPF exposure in amphibians but based on the transcriptomic response in the present 
study and response in zebrafish, altered behavioural responses may be a relevant adverse outcome 
to CPF in amphibians as well.  
2.6 Conclusion  
 This work demonstrated that short-term (96 h) exposure to CPF during early stages of 
larval development has the potential to disrupt many important pathways and processes in the 
model amphibian species, X. laevis. Physiological systems are often interdependent with both 
obvious and subtle overlap, and it is likely that the pathways found to be dysregulated in this 
study are linked to one another as well as to apical outcomes of exposure. Pathway analysis of 
the transcriptomic data attests that various metabolic pathways and enzymatic processes are 




CPF exposure was carried through to metamorphic climax. In terms of novel transcriptomic 
pathways identified in this study, immune function, cardiovascular development, metabolic 
processes, and behavioural responses to light stimulus are biological processes that could be a 
target for CPF in amphibians, with consequences for apical outcomes that should be explored. 
This study contributes to a better understanding of the potential consequences of chronic 
exposure of amphibians to environmental concentrations of CPF, suggesting that this widespread 





















EFFECT OF CHLORPYRIFOS, ALONE AND COMBINED WITH A 
LIPOPOLYSACCHARIDE CHALLENGE, ON IMMUNE PARAMETERS IN THE 




 Chlorpyrifos (CPF) has known immunotoxic effects in fish species, but the research 
regarding the immunotoxicity of the pesticide in amphibians is relatively scarce. In the previous 
chapter, we used whole transcriptome analysis to demonstrate that short-term, early life stage 
exposure to CPF in Xenopus laevis leads to disruption of a number of biological pathways 
related to immunotoxicity. This aided in design of the second study that focused on the immune 
system for a system-specific assessment of CPF impacts in amphibians. In this study, we further 
examined the potential immunotoxicity of CPF in the model amphibian species, X. laevis, using 
an immune challenge exposure model. The immune challenge assay allows for evaluation of a 
host’s ability to mount an appropriate immune response when challenged with a known 
immunostimulatory agent after exposure to a potential immunotoxic chemical. The objectives of 
the present study were to: (1) evaluate the effects of short-term exposure (seven days) to sub-
lethal concentrations of CPF on immune-related parameters in the amphibian X. laevis, and (2) 
determine whether exposure to CPF alters their ability to mount an immune response when 
challenged with lipopolysaccharide (LPS), a known immunostimulatory agent. Specific 
endpoints measured were histopathology of kidney tissues, circulating blood leukocyte 
populations, and expression of key pro-inflammatory cytokines in the liver. This chapter is being 
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Numerous contaminants present in the aquatic environment have the potential to disrupt 
immune defences and potentially increase disease susceptibility. Amphibians are known to 
inhabit contaminated environments, and there is growing concern that known immunotoxic 
chemicals may magnify the impacts of globally emerging infectious diseases. Chlorpyrifos 
(CPF) is one of the most commonly used organophosphate pesticides in Canada and worldwide. 
This pesticide can induce a variety of adverse effects in non-target aquatic vertebrates, including 
immunomodulation; however, studies specifically on amphibians are lacking. The objectives of 
this study were to (1) determine if short-term exposure to CPF results in immunomodulation in 
juvenile Xenopus laevis, the model amphibian species and, (2) determine if this 
immunomodulation results in impaired ability to mount a response to a simulated pathogen, 
lipopolysaccharide (LPS). Individuals were aqueously exposed to CPF (1 or 10 µg L-1) for seven 
days, then injected with either phosphate buffered saline (PBS; immune-rested) or 10 µg g-1 LPS 
(immune-stimulated) and sampled one day post-injection. Differential leukocyte profiles (by 
flow cytometry), expression of cytokines in the liver (by qPCR), and histopathology of the 
kidney were assessed in immune-rested and immune-stimulated individuals.  Exposure to 10 µg 
L−1 CPF resulted in an increase in kidney epithelial cell height (18% compared to control). 
Individuals exposed to CPF also displayed an overall reduction in circulating lymphocytes, an 
increase in circulating granulocytes, and increased expression pro-inflammatory cytokines, TNF-
α and CSF-1, in the liver. This study demonstrates that CPF can modulate the inflammatory 
immune parameters, providing some of the first evidence of the immunotoxic potential of CPF in 
amphibians. Given the fundamental role of inflammation in immune responses, these findings 
suggest that exposure to CPF may have consequences for amphibian susceptibility to 





  Chlorpyrifos (CPF; C9H11Cl3NO3PS) is one of the most commonly used organophosphate 
(OP) pesticides in Canada and worldwide (Adeyinka and Pierre, 2019). Numerous studies have 
assessed CPF concentrations in various aquatic systems around the world, with concentrations as 
high as 3.7 µg L−1 reported in agriculturally intense areas in North America (Zhang et al., 2012). 
Chlorpyrifos contamination of aquatic ecosystems poses a threat to the non-target species 
inhabiting these systems. The main mechanism of toxic action of CPF is inhibition of 
acetylcholinesterase (AChE), the enzyme responsible for the breakdown of acetylcholine (ACh) 
at nerve synapses (Fukuto, 1990). The accumulation of ACh at nerve junctions causes 
uncontrolled firing of neurons resulting in secondary effects that can lead to the death of fish and 
other aquatic animals (Fukuto, 1990; Kienle et al., 2009; Watson et al., 2014). Exposure of 
aquatic vertebrates to CPF can also alter a wide range of physiological parameters including 
growth and development (Kharkongor et al., 2018; McClelland et al., 2018; Tussellino et al., 
2016), oxidative stress (Jin et al., 2015; Zahran et al., 2018), cellular integrity (Ali et al., 2009; 
Altun et al., 2017), and immune response (Chen et al., 2014; Li et al., 2013; Wang et al., 2011). 
To date, most of the detailed studies specifically regarding CPF immunomodulation have been 
conducted in rats with clear effects on a variety of immune parameters, including pathology of 
immune organs, changes in immune cell populations, and reduced responsiveness to immune 
stimulating factors (Mokarizadeh et al., 2015; Oostingh et al., 2009).    
Studies on immune-related outcomes of CPF exposure in aquatic species are largely 
biased towards fish, with reported effects such as histopathological changes in key immune 
organs, altered immune parameters (e.g. leukocyte populations, cytokine expression) and 
decreased resistance to pathogen infection. In both fish and amphibians, the kidney is a key 
immune organ (Chen and Robert, 2011; Zhang et al., 2017) and an infection target for some 
pathogens such as Ranavirus, a prevalent viral agent plaguing wild amphibian populations (De 
Jesús Andino et al., 2012; Wendel et al., 2018). Changes in kidney structures such as tubules, 
glomeruli and interstitial connective tissues in fish following CPF exposure have been observed 
in various species, including Danio rerio (Scheil et al., 2009), Oreochromis niloticus (Zahran et 
al., 2018), Cyprinus carpio (Altun et al., 2017; Wang et al., 2013; Xing et al., 2012) and this 
tissue damaged is often attributed to oxidative stress. In a study by Xing et al. (2015), the kidney 




detectable after up to 40 days of depuration. Leukocytes (or white blood cells) play diverse and 
complex roles in the inflammatory response to pathogens. Fish exposed to CPF have displayed 
altered circulating leukocyte populations including lymphocytes (Adewumi et al., 2018; Ali et 
al., 2009; Zahran et al., 2018), granulocytes (Maharajan et al., 2017), and monocytes (Adewumi 
et al., 2018; Raibeemol and Chitra, 2018). Changes in cell populations are sometimes observed 
together with altered expression of cytokines (Zahran et al., 2018), effector molecules that are 
synthesized and secreted by immune cells and are vital in modulating the amplitude of an 
immune response. Specific roles of cytokines identified in vertebrates (including amphibians) 
include initiation of pro-inflammatory cascades (De Jesús Andino et al., 2012), macrophage 
activation and recruitment (Wang et al., 2011; Zahran et al., 2018), and development, 
differentiation, and proliferation of phagocytes (Grayfer and Robert, 2016). Across many fish 
species, exposure to CPF is reported to upregulate expression of  tumor necrosis factor alpha 
(TNF-α) (Chen et al., 2014; Jin et al., 2015; Zahran et al., 2018) as well as interleukin 1-beta (IL-
1β) (Jin et al., 2015; Wang et al., 2011; Zahran et al., 2018). While there is clear evidence that 
CPF exposure can have immunomodulatory effects in fish, similar studies with amphibians are 
scarce despite the hypothesized links between pesticide contamination of aquatic environments 
and globally declining amphibian populations (Davidson, 2004; Hayes et al., 2006; Sparling and 
Fellers, 2009).  
The impact of pesticides, such as CPF, entering the aquatic environment and their 
potential immunomodulatory effects in amphibians are of particular concern. Amphibian 
populations have been declining globally since the 1980s (Hayes et al., 2010; Rollins-Smith, 
1998; Stuart et al., 2004). The reasons for this decline are complex with a number of potential 
contributing factors including climate change, habitat loss, anthropogenic chemical 
contamination, and presence of opportunistic pathogens (Carey et al., 1999; Miller et al., 2011). 
Environmental stressors rarely occur in isolation and it is likely that a combination of these 
factors play a role in localized mass mortality events and global declines. Exposure to 
environmental contaminants may alter components of the immune system, resulting in a level of 
immunomodulation that impairs an individual’s ability to mount an effective immune response to 
pathogens encountered in their environment thus leading to infection, disease, and mortality 
(Buck et al., 2015). Resistance to pathogens encountered in the environment involves aspects of 




tadpole stages (pro-metamorphosis) and continuing into early metamorphosis, the amphibian 
immune system undergoes a substantial reorganization, which is accompanied by 
immunosuppression that persists for up to six months post-metamorphosis (Grogan et al., 2018). 
Exposure to environmental contaminants during these sensitive early life-stages may lead to 
long-term impacts on the organism’s ability to defend against pathogen infection. Although it is 
difficult to make causative links, immunomodulation due to exposure to anthropogenic 
contaminants and increased susceptibility to disease have been implicated in localized mass 
mortality events of amphibian populations, as well as widespread declines (Carey et al., 1999; 
Hayes et al., 2010).  
The objective of the present study was to determine the effects of short-term exposure to 
sub-lethal concentrations of CPF on immune-related parameters in the amphibian Xenopus laevis 
and to evaluate whether exposure to CPF alters their ability to mount an immune response when 
challenged with lipopolysaccharide (LPS), a known immunostimulatory agent. A major 
component of the bacterial outer cell wall membrane, LPS is often used in immunotoxicology 
studies to stimulate the inflammatory response and simulate a pathogen infection (Swain et al., 
2008). We conducted an immune challenge study and examined the effects on immune-related 
parameters in both non-stimulated and immune-stimulated (LPS-injected) individuals. Specific 
endpoints evaluated included histopathology of kidney tissues, circulating blood leukocyte 
populations, and expression of key pro-inflammatory cytokines in the liver. Concentrations of 
CPF chosen for the short-term exposure were within range of those found in aquatic systems; for 
example, concentrations of CPF have been recently reported as high as 3.7 µg L−1 in 
agriculturally intensive areas in North America (Uniyal and Kumar Sharma, 2018).  The CPF 
concentrations chosen are also considered sub-lethal for amphibians (based on previous literature 
3.3 Materials and Methods 
3.3.1 Obtaining Xenopus laevis for exposures 
An adult X. laevis colony was maintained under a 12 hours (h) light:12 h dark 
photoperiod at 16 ± 1 °C in the Aquatic Toxicology Research Facility at the Toxicology Centre, 
University of Saskatchewan, Saskatoon, SK. Four sexually mature males and females were 




priming dose of human chorionic gonadotropin (hCG, Sigma-Aldrich, St. Louis, MN, United 
States) dissolved in sterilized phosphate buffered saline (PBS;137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2PO4). After priming injections males and females were housed in 
separate aquaria at 21 ± l °C overnight. A second dose of hCG was administered approximately 
24 h after priming injections; males received a 250 IU dose and females received a 500 IU dose. 
Breeding pairs were then selected at random, placed into aquaria with water temperature 
maintained at 21 ± 1 °C, and left to spawn overnight.  
After collection, selection and preparation of embryos followed protocols outlined in 
“Standard guide for conducting the Frog Embryo Teratogenesis Assay-Xenopus (FETAX)” 
(ASTM, 2012). A maximum of 50 normally cleaving embryos were placed in individual egg 
cups, a vertical PVC pipe with two holes cut below a 100 μm Teflon mesh insert, to incubate in 
facility water maintained at 22 ± 1 °C for 24 h. After this incubation period tadpoles were reared 
in a Min-O-Cool tank (Frigid Units Inc., Toledo, OH, United States) under a 12 h light:12 h dark 
photoperiod at 21 ± 1 °C until they reached Nieuwkoop Faber (NF) stage 65 (Nieuwkoop and 
Faber, 1994). Tadpoles were fed SeraMicron (Sera, Heinsberg, Germany) ad libitum daily and 
then transitioned to Arcadia EarthPro Amphibigold pellets (Arcadia Reptile, Mepal, 
Cambridgeshire, England) at metamorphosis. Animals used in this study were handled in 
accordance with the University of Saskatchewan’s Animal Research Ethics Board (protocol no. 
20130045) and adhered to the Canadian Council on Animal Care guidelines for humane animal 
use.  
3.3.2 Short-term chlorpyrifos exposure with LPS challenge 
Chlorpyrifos powder (CAS: 2921-88-2, purity: 98%) was purchased from TRC Canada 
(North York, ON, Canada). Stock concentrations of 10 and 100 µg L−1 CPF were prepared in 
dimethyl sulfoxide (DMSO) and added to exposure tanks for a final solvent concentration of 
0.01% v/v and nominal CPF exposure concentrations of 1 and 10 µg L−1, respectively.  
Sixty individuals at NF stage 65 were transferred from the general population into 7 L 
tanks (5 individuals/tank) in a temperature controlled environmental chamber for a one-week 
acclimation period under a 16 h light:8 h dark photoperiod at 21 ± l °C.  Frogs were fed crushed 
Arcadia EarthPro Amphibigold pellets ad libitum daily throughout the acclimation and the 




even distribution of sizes across treatments. Individuals were exposed to CPF for seven days 
under static renewal conditions with four tanks per treatment and five individuals per tank (n=20 
individuals/CPF treatment). Water parameters were recorded daily (pH 7-7.5, dissolved oxygen 
> 90%, temperature = 20 ± 0.5°C) and a 75% water change was conducted where tanks were re-
dosed with CPF to maintain the nominal target concentrations. During the exposure period water 
quality was monitored daily (Appendix C) and 75% water renewal was conducted where tanks 
were re-dosed with CPF to maintain the nominal target concentrations.  
After seven days of CPF exposure, each CPF treatment was divided so that ten 
individuals received PBS injection and ten received the LPS injection. This resulted in a 2 x 3 
factorial design, with six unique treatments and 10 individuals per treatment. LPS (E. coli 
055:B5; Sigma-Aldrich, St. Louis, MN, USA) was solubilized in sterile PBS on the day of 
injections. Animals were lightly anesthetized by immersion in buffered 0.2 g L-1 tricaine 
methanesulfate (MS-222) prior to injection and then injected intraperitoneally on the lower left 
portion of the abdomen with sterilized PBS or with 10 µg LPS g−1 body weight using a 29-gauge 
needle. Following injections, PBS-injected and LPS-injected individuals of each CPF treatment 
group were housed separately in clean facility water.  
Individuals were sampled one day post-injection (1 dpi). This time frame was chosen 
based on data from previous work with LPS showing maximal immune stimulatory response 
(Gallant and Hogan, unpublished). Individuals were euthanized by immersion in buffered 0.1% 
MS-222 and morphometric endpoints such as wet body weight (to the nearest 0.01 g), total body 
length (to the nearest 0.01 cm), and liver weight (to the nearest 0.01 g) were measured and 
recorded (n = 9 for solvent groups; n = 10 for 1 and 10 µg L−1 CPF treatment groups). Whole 
blood (10 µl) was collected from each individual by cardiac puncture with a heparinized 
hematocrit tube. Livers were excised, weighed (to the nearest 0.01 g), and immediately flash 
frozen for targeted gene expression analysis. The whole carcasses with all other organs intact 
were then submerged in CalEx-II (Fisher Scientific, Hampton, NH, United States) for 48 h of 
fixing and decalcifying prior to transfer into 70% ethanol for preservation. 
3.3.3 Kidney histology 
Kidneys from each individual were excised, placed into a tissue embedding histocassette, 




processing, kidneys were embedded in paraffin wax. Each kidney was longitudinally sectioned at 
a thickness of 6 µm, mounted on slides, and dried at 37 °C for approximately 12 h. Sections were 
stained with regressive hematoxylin and eosin (H&E) and examined using an Olympus BX41 
microscope (Olympus, Center Valley, PA, United States). Photographs of each slide were taken 
using an attached Olympus DP71 camera and the associate DP Manager software (Olympus). 
One section at the same plane of view per kidney was chosen for measurement of tubule 
epithelial cell height. Ten tubules were chosen at random from each section and four random 
epithelial cells within each tubule were measured. Measurement of kidney tubule epithelial cells 
was performed blinded using the open source ImageJ 1.x software (Bethesda, Rockville, MD, 
United States). 
3.3.4 Leukocyte profiles using DiOC5(3) staining and flow cytometry 
Blood collected during the sampling period was transferred from the hematocrit tube to a 
heparinized vacutainer (32 IU sodium heparin; BD Bioscience, Franklin Lakes, NJ, USA) 
containing 1 mL cold PBS to prevent coagulation. Samples were taken in duplicate per 
individual and stored on ice for a maximum of 1 h before staining and preparation for flow 
cytometry analysis as described in Burraco et al. (2017). Briefly, 1 µL of 2 mM 3,3’-
dipentyloxacarbocyanine iodide (DiOC5(3)) dye was added to the blood and PBS solution, for a 
final concentration of 2 µM DiOC5(3). Samples were mixed and incubated at room temperature 
for 5 min, centrifuged at 4°C for 5 min at 1000 rpm, and then supernatant was aspirated prior to 
re-suspension of the cells in 1 mL PBS. Stained samples were analyzed by flow cytometry on the 
Accuri C6 (BD Bioscience), where 100,000 events were recorded per sample. In each sample, 
erythrocytes, lymphocytes, monocytes, and granulocytes were identified based on side scatter 
measuring the granularity or complexity of the cell and the fluorescent intensity of the cell in the 
FL1 channel. Each homogeneous cell population was gated, and event rate and population 
percentage were calculated using the BD Accuri C6 Plus software (BD Biosciences). 
3.3.5 Gene expression analysis of pro-inflammatory cytokines  
 Liver tissues were disrupted using an Omni Bead Ruptor (Omni International, 
Kennesaw, GA, USA) for two 45 second (s) cycles. Total liver mRNA was obtained using TRI 




suspended in RNase-free water. Concentration of RNA was measured using a Nanodrop-1000 
spectrophotometer (Thermo Fisher Scientific, Waltham, United States) and RNA quality was 
confirmed on a 1% agarose gel. Genomic DNA (gDNA) cleanup and complementary DNA 
(cDNA) synthesis of 1 μg total RNA was performed using the QuantiTect reverse transcription 
kit (Qiagen, Mississauga, ON, Canada) as described by the manufacturer. 
Gene expression analysis was performed by qPCR using the CFX96 Real-time C1000 
Thermal Cycler (Bio-Rad Laboratories) and SsoFast EvaGreen Supermix (Bio-Rad Laboratories) 
using previously described methods (Gallant and Hogan, 2018). Gene-specific primer sets 
(Invitrogen, Carlsbad, CA, United States) for target genes IL-1β, TNF-α, and CSF-1 as well as 
GAPDH and EF1α (reference genes) are detailed in Table 3.1. Briefly, each 20 µL qPCR 
reaction volume contained 1x SsoFast EvaGreen Supermix (Bio-Rad Laboratories), optimized 
concentrations of each primer set, and 2 µL of diluted cDNA template. Samples were run in 
duplicate and a no template and no reverse transcriptase control were included on each plate. A 
standard curve made from a serially diluted pool of cDNA was also included on each plate for 
interpolation of relative mRNA abundance of targeted genes in each sample. Each standard curve 
had an R2 > 98%. The thermal cycle program was comprised of an enzyme activation at 95 °C 
for 30 s, 40 amplification cycles at 95 °C for 5 s and 5 s at the gene specific annealing 
temperature (Table 3.1), denaturation at 95 °C for 1 min, and melt curve analysis from 55 °C to 
95 °C (increasing 1 °C every 30 s). The mean starting quantity of each sample was normalized to 
the geometric mean of the reference genes, EF-1 and GAPDH. Data are presented as fold-change 











Table 3.1 List of target genes and associated forward and reverse primers used for transcript expression analysis by qPCR in Xenopus 
laevis liver tissues. 








IL-1β FWD GGCCTCAATGAAACCTCCAC NM_001085605.1 232 60 (Gallant and 
Hogan, 2018) REV AGGCAGATATCTCCCAGCAC 
 
TNF-α FWD TGTCAGGCAGGAAAGAAGCA AB298595.1 203 62 (Sifkarovski et 
al., 2014) REV CAGCAGAGAGCAAAGAGGATGGT 
 
CSF-1 FWD ATCGAACTCTGTCCAAGCTGGATG NM_001280600.1 123 60 (Sifkarovski et 
al., 2014) REV GGACGAAGCAAGCATCTGCCTTAT 
 
GADPH FWD GACATCAAGGCCGCCATTAAGACT AF549496.1 130 58.4 (Sifkarovski et 
al., 2014) REV AGATGGAGGAGTGAGTGTCACCAT 
 
EF-1 FWD GAGGGTAGTCTGAGAAGCTCTCCACG NM_001086133.1 221 60 (Gallant and 
Hogan, 2018) REV CCTGAATCACCCAGGCCAGATTGGTG 
 





3.3.6 Statistical analysis 
Data were tested for a normal distribution using the Shapiro-Wilk test and for 
homoscedasticity using Levene’s test. In cases where data failed the assumptions of parametric 
statistics, a log transformation was applied and data was reanalyzed. Data were analyzed using a 
two-way ANOVA (CPF exposure × LPS challenge). In cases where a CPF × LPS interaction was 
significant (interaction p ≤ 0.05), pairwise comparisons were applied with a Bonferroni-adjusted 
p value. In cases where there was no significant interaction detected (interaction p > 0.05), each 
main factor (CPF exposure and LPS challenge) was interpreted and if found significant (p ≤ 
0.05), groups were distinguished using the appropriate post-hoc test (Tukey’s HSD for CPF 
exposure and multiple pair-wise comparisons test for LPS challenge). Hypothesis testing was 
two-tailed. All analyses were conducted using SPSS Statistics 25 (IBM Corporation, Armonk, 
NY, United States) and graphs were generated using Prism 8 (GraphPad Software, La Jolla, CA, 
USA). 
3.4 Results 
3.4.1 Morphometrics  
Two individuals died with undetermined cause in the 0.01% DMSO treatment during the 
7 day (d) CPF exposure period and prior to injection. There was no effect of CPF exposure on 
body weight (CPF: F(2,58)= 0.246, p = 0.783; LPS: F(1,58)= 0.731, p = 0.396; CPF × LPS: F(2,58)= 
0.190, p = 0.828) or total length (CPF: F(2,58)= 0.403, p = 0.671; LPS: F(1,58)= 0.270, p = 0.606; 
CPF × LPS: F(2,58)= 0.304, p = 0.739) following CPF exposure with LPS challenge (Appendix 
D). There was no difference in relative liver weight across treatments (CPF: F(2,57)= 0.814, p = 
0.449; LPS: F(1,57)= 3.727, p = 0.059; CPF × LPS: F(2,57) = 0.265, p = 0.768); however, there was 
a trend towards higher relative liver weights in individuals injected with LPS. 
3.4.2 Effects of CPF on kidney histology 
There was no significant interaction between CPF × LPS (F(2,36)= 2.667, p = 0.086) on 
kidney epithelial cell height (Fig. 3.1) but there were main effects of both CPF exposure (F(2,36)= 
10.702, p ≤ 0.01) and LPS challenge (F(1,36)= 17.454, p ≤ 0.01). Regardless of challenge state, 




the 0.01% DMSO control group (mean ± SEM; 7.126 ± 0.424 μm vs 8.689 ± 0.217 μm; p ≤ 
0.001). Upon observation, the tubules appeared swollen with a reduction in lumen size (Fig. 3.2). 
Kidney epithelial cell height also increased with LPS injection when compared with PBS-





Figure 3.1. Effects of chlorpyrifos (CPF) exposure and lipopolysaccharide (LPS) challenge, 
alone and in combination, on mean (± SEM) kidney tubule epithelial cell height in metamorphic 
X. laevis. Individuals were exposed to CPF for 7 days and then injected with phosphate buffered 
saline (PBS) or LPS (10 µg g-1) and sampled 1 dpi. Ten tubules from each kidney (n=6 
individuals/treatment group) were randomly selected and four epithelial cells per tubule were 
measured. Data were analyzed using two-way ANOVA with CPF exposure and LPS challenge as 
factors. Letters indicate significant differences among CPF exposure (p ≤ 0.05) and * indicates 
significant effect of LPS injection (p ≤ 0.05). 
  



































Figure 3.2. Photomicrographs of hematoxylin and eosin stained kidney sections from 
metamorphic X. laevis after 7 day exposure to chlorpyrifos (CPF). (A) Representative section 
from kidney of individual exposed to 0.01% DMSO control + PBS-injected showing normal 
organization of structures. (B) Representative section of kidney from an individual exposed to 10 
µg L−1 CPF + PBS-injected showing epithelial cell hypertrophy and decreased lumen size in 
convoluted tubules. G = glomerulus, dt = distal convoluted tubule, pt = proximal convoluted 




3.4.3 Effects of CPF on basal and LPS-stimulated leukocyte populations 
For the proportion of lymphocytes in blood (Fig. 3.3A), there were main effects of both 
CPF exposure (F(2,58)= 3.973, p = 0.025) and LPS challenge (F(1,58)= 95.664, p ≤ 0.001) but no 
interaction between factors (F(2,58)= 0.061, p = 0.941). Individuals exposed to 1 µg L
−1 CPF had 
lower proportion of circulating lymphocytes compared to those exposed to 0.01% DMSO (p = 
0.020), but this was not observed in the 10 µg L−1 CPF treatment group (p = 0.218). There was 
also an overall decrease in circulating lymphocytes in the LPS-injected animals compared to 
those injected with PBS (p ≤ 0.001). For blood monocyte populations (Fig. 3.3B), there was a 
main effect of LPS challenge (F(1,58)= 107.763, p ≤ 0.001) but no main effect of CPF exposure 
(F(2,58)= 0.053, p = 0.949) or interaction between CPF exposure and LPS challenge (F(2,58)= 
1.115, p = 0.336). Circulating monocyte populations increased after LPS injection compared to 
PBS-injected individuals (p ≤ 0.001).There was a main effect of CPF exposure (F(2,58)= 5.299, p 
= 0.008) on circulating granulocytes (Fig. 3.3C) where individuals exposed to 1 µg L−1 CPF had 
higher circulating granulocytes when compared to the 0.01% DMSO control (p = 0.007) but this 
increase was not present in the 10 µg L−1 CPF exposure group (p = 0.071). There was no main 
effect of LPS challenge (F(1,58)= 1.830, p = 0.182) on proportion of circulating granulocytes and 
no interaction between CPF exposure and LPS challenge (F(2,58)= 1.557, p = 0.220). There were 
main effects of both CPF exposure (F(2,58)= 4.725, p = 0.013) and LPS challenge (F(1,58)= 11.540, 
p = 0.001) on the granulocyte:lymphocyte (GL) ratio (Fig. 3.3D) but no interaction between 
main factors (F(2,58)= 0.455, p = 0.637). When compared to individuals exposed to 0.01% 
DMSO, there was an increase in the GL ratio with exposure to 1 µg L−1 CPF (p = 0.002) and 10 
µg L−1 CPF (p = 0.028). There was also an increase in the GL ratio in individuals injected with 







Figure 3.3. Effects of chlorpyrifos (CPF) exposure and lipopolysaccharide (LPS) challenge on 
the proportion of (A) lymphocytes, (B) granulocytes, (C) monocytes, and (D) 
granulocyte:lymphocyte (GL) ratio in whole blood of X. laevis as measured by DiOC5(3) 
staining and flow cytometry. Individuals were exposed to CPF for 7 days and then injected with 
phosphate buffered saline (PBS) or LPS (10 µg/g) and sampled 1 dpi. Bars represent mean ± 
SEM (n = 9-10). Data were analyzed using two-way ANOVA with CPF exposure and LPS 
challenge as factors. Letters indicate significant differences across CPF exposure and * indicates 
significant effect of LPS injection (p ≤ 0.05).  




















































































3.4.4 Effect of CPF on LPS-stimulated expression of pro-inflammatory cytokines 
Levels of TNF-α mRNA were affected by both CPF exposure (F(2,33)= 3.726, p = 0.037) 
and LPS challenge (F(1,33)= 34.607, p ≤ 0.001) but there was no interaction between the two 
factors (F(2,33)= 0.503, p = 0.610; Fig. 3.4A). Individuals exposed to 10 µg L
−1 CPF had increased 
liver TNF-α mRNA expression when compared with the 0.01% DMSO treatment group (p = 
0.044). Liver TNF-α mRNA levels were also increased in LPS-injected individuals when 
compared to those injected with PBS (p ≤ 0.001). Similarly, CSF-1 expression was altered with 
exposure to CPF (F(2,35)= 3.723, p = 0.036) and there was also a main effect of LPS challenge 
(F(1,35)= 15.747, p ≤ 0.001) but there was no interaction between factors (F(2,35)= 0.639, p = 
0.535; Fig. 3.4B). Expression of CSF-1 in the liver was increased with exposure to 10 µg L−1 
CPF compared to the 0.01% DMSO control (p = 0.044) and after LPS injection compared to 
PBS-injected individuals (p ≤ 0.001). There was a main stimulatory effect of LPS challenge on 
expression of IL-1β (F(1,34)= 36.562, p ≤ 0.001) but no effects of CPF exposure (F(2,34) = 1.213, p 
= 0.312) or interaction between factors (F(2,34)= 2.021, p = 0.151; Fig. 3.4C). Expression of IL-1β 
in liver was significantly increased in individuals injected with LPS as compared to the PBS-







Figure 3.4. Effects of chlorpyrifos (CPF) exposure and lipopolysaccharide (LPS) challenge on 
mRNA expression of (A) tumor necrosis factor α (TNF-α), (B) colony stimulating factor 1 (CSF-
1), and (C) interleukin 1β (IL-1β) in liver of X. laevis as measured by qPCR. Individuals were 
exposed to CPF for 7 days and then injected with phosphate buffered saline (PBS) or LPS (10 
µg/g) and sampled 1 dpi. Data were normalized to the geometric mean of GAPDH and EF1α and 
expressed relative to the 0.001% DMSO + PBS-injected group. Bars represent the mean ± SEM 
(n = 6). Data were analyzed using two-way ANOVA with CPF exposure and LPS challenge as 
factors. Different letters indicate significant differences between CPF concentrations and * 
indicates significant effect of LPS injection (p ≤ 0.05). 
 


































































































The objective of this study was to assess the immunomodulatory effects of CPF exposure 
in the laboratory model amphibian species, X. laevis, using an immune challenge approach. We 
found that short-term (7 d) exposure to 1 and 10 µg L−1 CPF resulted in structural changes in the 
kidney, altered specific circulating leukocyte populations, and increased expression of pro-
inflammatory cytokines. This study provides some of the first evidence of the immunotoxic 
effects of CPF in amphibians and indicates that exposure to CPF may impair the ability of 
amphibians to resist pathogen infection with consequences for disease occurrence.  
When analyzed by flow cytometry, the proportion of different leukocyte populations in 
peripheral blood changed with both CPF exposure and with LPS-stimulated immune challenge. 
Exposure to 1 µg L−1 CPF resulted in a decrease in circulating lymphocytes and an increase in 
circulating granulocytes and this effect was independent of the LPS challenge. A decrease in 
circulating lymphocytes and an increase in circulating granulocytes is characteristic of a 
chemical or biological stress response in amphibians (reviewed in Davis et al., 2008). Exposure 
to CPF has been associated with decreased circulating lymphocytes in a variety of vertebrates 
including rats (Rattus norvegicus) (Elelaimy et al., 2012; Goel et al., 2006), chickens (Gallus 
domesticus) (Begum et al., 2015), and catfish (Clarias gariepinus) (Adewumi et al., 2018). 
Increased circulating granulocyte populations after CPF exposure have been reported in species 
across taxa, including silk worm (Philosamia ricini) (Kankana Kalita and Devi, 2016), rats (R. 
norvegicus) (Elelaimy et al., 2012), and fresh water crab (Paratelphusa jacquemontii) 
(Maharajan et al., 2017). Interestingly, the effect of CPF exposure at 1 µg L−1 was not observed 
at 10 µg L−1 CPF where both lymphocyte and granulocyte populations were the same as control 
group. However, exposure to both 1 and 10 µg L−1 CPF increased the GL ratio, which is a 
composite measure of the stress response and is considered a more relevant parameter than 
looking at either leukocyte population alone (Davis et al., 2008; Uchendu et al., 2018). In birds, 
an elevated GL ratio has been linked to increased susceptibility to infection (Al-Murrani et al., 
2002) and an increase in GL ratio is positively related to both the magnitude of the stressor and 
circulating glucocorticoids in most vertebrates (reviewed in Davis et al., 2008). Based on this 
composite measure of inflammatory state, it appears that exposure to 1 and 10 µg L−1 CPF can 
induce an inflammatory response in metamorphic X. laevis. It is also important to note that for 




amphibians (based on previous studies) and that were environmentally relevant. These 
concentrations were not confirmed analytically and are likely to fall below the nominal values, 
based on what is known about CPF physicochemical properties including adsorption to glass 
(Thomas and Mansingh, 2002) and algae (Giddings et al., 2014), and a high escaping tendency in 
laboratory exposure systems (Manzanti et al., 2003). Therefore, we would hypothesize that CPF 
exposure could have effects on immune parameters in amphibians at actual concentrations lower 
than those nominally tested in the present study.  
Expression of key pro-inflammatory cytokines, which are effector molecules that allow 
communication between components of the immune system, was also evaluated as an indicator 
of immune status. Pro-inflammatory cytokines have many important roles during the immune 
response to chemical or biological stress, including leukocyte production and migration 
(Nourshargh and Alon, 2014). We observed that exposure to 10 µg L−1 CPF increased liver 
mRNA levels of pro-inflammatory cytokines TNF-α and CSF-1. Increased TNF-α expression has 
been reported after CPF exposure in various fish species including C. carpio (Chen et al., 2014),  
O. niloticus (Zahran et al., 2018), and D. rerio (Jin et al., 2015). Upregulation of TNF-α is 
indicative of an inflammatory response and expression of TNF-α is rapidly induced after viral 
and bacterial infection in fish and amphibians (Morales et al., 2010; Teles et al., 2011). During 
the innate immune response, TNF-α induces apoptosis and enhances granulocyte migration 
(Erger and Casale, 1998; MacKenzie et al., 2003). A potential explanation for the apparent return 
to basal levels of granulocytes observed in the 10 µg L−1 CPF group may be due, in part, to the 
increased expression of TNF-α enhancing migration of granulocytes out of circulation and into 
tissues, such as the kidney. CSF-1 is one of the principal mediators of the development, 
differentiation, proliferation, and survival of macrophages across vertebrates, including 
amphibians (Grayfer and Robert, 2014; Pixley and Stanley, 2004). Currently, there are no studies 
characterizing the response of CSF-1 to CPF or any OP pesticide exposure in aquatic vertebrates, 
although our results indicate that exposure to CPF can induce CSF-1 expression in X. laevis. 
Monocytes are the activated precursors to macrophages, and in the present study there was no 
apparent effect of CPF exposure on circulating monocyte populations. CSF-1 is critically 
involved in proliferation and differentiation of progenitor cells into macrophages, so it is possible 




monocytes and may explain, in part, the apparent return to basal monocyte levels at the highest 
CPF concentration. 
 Histological examination of kidney tissues from CPF-exposed X. laevis revealed an 
increase in kidney epithelial cell size in individuals exposed to 10 µg L−1 CPF. Hypertrophy of 
kidney epithelial cells and decreased lumen size with exposure CPF has been reported in a 
number of species including rats (R. norvegicus) and common carp (C. carpio) (Raina and 
Hamid, 2013; Xing et al., 2015). The kidney plays a dual role in amphibians, both as a key 
component of body fluid homeostasis and an immune organ (Carey and Bryant, 1995), and is the 
known target organ for Ranavirus, an environmentally relevant pathogen of concern that has 
been implicated in globally declining amphibian populations (Daszak et al., 1999; Miller et al., 
2011). Kidney epithelial cells also play a role in the innate immune response and act as both the 
site of production and cellular target for inflammatory mediators such as pro-inflammatory 
cytokines and leukocytes (Cantaluppi et al., 2014). In a recent study by Zhang et al. (2017), 
transcriptomic responses were assessed in head kidney of common carp (C. carpio) after CPF 
exposure and pathways related to immune response, immune system processes, and cytokine 
activity and function were significantly upregulated. As kidney epithelial cells are an active site 
of cytokine production, CPF-induced inflammation resulting in increased production and release 
of pro-inflammatory cytokines, such as TNF-α and CSF-1, may be contributing to the observed 
cellular hypertrophy, along with tissue damage associated with this inflammatory response. In 
this study, histopathological examination of kidney tissue did not include lymphoid tissue which 
would lend further insight into the immunotoxicological effects of CPF exposure in X. laevis. 
In our study, X. laevis mounted an appropriate molecular and cellular response to LPS 
although this characteristic response did not appear to be impacted by CPF. When compared to 
the PBS-injected group, LPS-injected individuals had lower circulating lymphocytes, increased 
monocytes, and increased GL ratio in whole blood. The observed changes in lymphocytes and 
GL ratio are characteristic of amphibians in stressed states, such as after exposure to 
corticosterone (Falso et al., 2015) and hydrocortisone (Bennett et al., 1972). In fish, LPS 
exposure is reported to increase circulating monocyte populations (Swain et al., 2008), which is 
consistent with the results of our study. There is a lack published data on changes in blood 
monocyte population in response to stress; however, in a previous study by our lab, there was a 




unpublished). In contrast, Falso et al. (2015) reported no change in circulating monocyte 
populations in X. laevis or Lithobates catesbeianus with long-term corticosterone exposure.  
Interestingly, an increase in circulating granulocytes is also a characteristic response in 
amphibians in stressed conditions (reviewed in Davis et al., 2008) and this was not observed in 
our study. However, in a recent study in three-spined stickleback (Gasterosteus aculeatus), the 
authors reported no change in proportion of granulocytes after 4 d exposure to CPF 
concentrations up to 1.75 µg L−1 followed by intraperitoneal LPS injection (Marchand et al., 
2017). In a separate immune-challenge study by our group, there was also no change in 
granulocyte populations after LPS injection in X. laevis and it was hypothesized that contrasting 
responses of different types of granulocytes (neutrophils and eosinophils), which are 
indistinguishable using the DiOC5(3) assay, may contribute to apparent lack of overall change in 
granulocytes (Gallant and Hogan, unpublished).  
The roles of leukocytes and cytokines in the inflammatory response are interdependent 
and so it was not surprising to find expression of pro-inflammatory cytokines TNF-α, IL-1β, and 
CSF-1 increased in liver of LPS-injected frogs. Both lymphocytes and activated macrophages 
(derived from monocytes) play critical roles in the synthesis and release of pro-inflammatory 
cytokines including TNF-α and IL-1β. (Arango Duque and Descoteaux, 2014; Swain et al., 
2008). Overall, it appears that LPS is an effective mitogen in amphibians, affecting leukocyte 
populations and pro-inflammatory cytokine expression as well as inducing hypertrophy of 
kidney epithelial cells.  
3.6 Conclusion 
 In this study, short-term (7 d) exposure to environmentally relevant concentrations of 
CPF resulted in changes to markers of immune status as well as histopathological changes of the 
kidney in metamorphic X. laevis. In general, exposure to CPF appeared to induce an 
inflammatory response independent of the LPS challenge but individuals were still able to mount 
an appropriate immune response to LPS exposure, specifically changes in targeted leukocyte 
populations and increased expression of pro-inflammatory cytokines. This research contributes 
to a better understanding of the potential immunotoxicity of CPF in amphibians in light of recent 
concern regarding pesticide contamination of aquatic systems, immunotoxicity and disease-




environmentally relevant pathogen, such as Ranavirus, could provide further insight into the 

























4.1 Project objective and focus 
 As the global demand for pesticide use increases, so too does the amount of these 
chemicals occurring within aquatic systems in Canada, North America, and worldwide. 
Chlorpyrifos (CPF), is one of the most commonly used organophosphate (OP) pesticides and has 
been measured in aquatic systems close to point sources as well as in remote and seemingly 
pristine locations (Adeyinka and Pierre, 2019; Muir et al., 2004). This ubiquitous contamination 
poses a threat to non-target species interacting with or inhabiting affected aquatic environments. 
Amphibian species are of particular concern due to potential links between pesticide 
contamination of aquatic ecosystems leading to increased susceptibility to pathogen infection 
and disease outbreaks (Carey et al., 1999). Exposure to CPF has been associated with a range of 
sub-lethal effects in aquatic vertebrates including morphometric abnormalities (Jin et al., 2015; 
Kleinhenz et al., 2012; Richards and Kendall, 2003), histopathological alteration across a range 
of tissues (Colombo et al., 2005; Scheil et al., 2009; Xing et al., 2012), acetylcholinesterase 
(AChE) inhibition (Colombo et al., 2005; Liendro et al., 2015; Richards and Kendall, 2002), 
immunotoxicity (Adel et al., 2017; Harford et al., 2005; Kerby and Storfer, 2009), oxidative 
stress (Liendro et al., 2015; Xing et al., 2012; Zhang et al., 2017), and changes in expression of 
target genes and transcriptomic profiles (Wang et al., 2018; Zahran et al., 2018; Zhang et al., 
2017). The overall objective of this thesis was to gain a better understanding of the sub-lethal 
effects of exposure to CPF on the model amphibian species, Xenopus laevis, and to provide 





The research conducted in Chapter 2 of this thesis aimed to characterize and compare the 
transcriptome responses of short-term early life stage (ELS) exposure to CPF in X. laevis and 
apical outcomes after chronic CPF exposure through to metamorphic climax. There were several 
reasons for choosing amphibians as the test animal and CPF as the chemical of interest. Firstly, 
amphibians are generally underrepresented in the toxicological literature and little is known 
related to sub-lethal effects of CPF exposure at environmentally relevant concentrations. 
Secondly, there is a complete lack of data regarding the effects of CPF on the transcriptome of 
amphibians which, if known, could help us understand underlying toxicity pathways leading to 
negative apical outcomes of exposure. Finally, this work was conducted as part of the 
EcoToxChip project, which aims to to develop and validate quantitative PCR arrays and a data 
evaluation tool (EcoToxXplorer.ca) for characterization, prioritization, and management of 
environmental contaminants in model laboratory species and native species of concern 
(www.ecotoxchip.ca; Basu et al., 2019). The pathway analysis in Chapter 2 revealed a number of 
pathways specifically related to immune functions and processes, suggesting that the developing 
immune system may be a target of CPF toxicity in ELS X. laevis. To determine whether this 
CPF-mediated ELS pathway dysregulation led to a functional impact, the immune system was 
selected as the focus for further examination. The research conducted in Chapter 3 of this thesis 
focused on immunotoxicity as a potential mode of action for adverse effects of CPF exposure in 
amphibians. The aim of this chapter was to determine if CPF was able to alter biomarkers of 
innate immunity and whether this translated to impairment in the ability to mount an effective 
immune response to a simulated pathogen, lipopolysaccharide (LPS). Again, there is a lack of 
literature regarding the effects of short-term, sub-lethal CPF exposure on the amphibian immune 
system despite evidence of immunotoxicity in various fish species. The limited studies that do 
exist in this context do not use an immune-challenge approach that actually evaluates the 
capacity for an individual to mount an immune response following exposure. Previous studies 
have also not examined impacts during the metamorphic life-stage. Amphibians undergo a 
widespread remodeling of many physiological systems, including the immune system, during 
metamorphosis and there is evidence that metamorphs are more sensitive to CPF exposure than 
pre-metamorphs in some cases (Richards and Kendall, 2003; Rollins-Smith, 1998). Thus, this 





4.2 Major findings and conclusions of research  
The research conducted as part of this thesis evaluated the effect of sub-lethal exposure to 
CPF in X. laevis across levels of biological organization from transcriptome to whole animal. 
Overall, exposure to CPF caused significant changes in several endpoints measured across 
various levels of biological organization. Effects of CPF exposure included dysregulation of 
pathways and expression of specific genes at the molecular level, changes in circulating 
leukocytes at the cellular level, histopathological alterations at the tissue/organ level, and 
morphometric changes at the level of the whole animal. 
In Chapter 2, 96 hour (h) exposure to CPF in ELS X. laevis resulted in upregulation of 
pathways associated with protein and carbohydrate metabolism, blood coagulation, tetrapyrrole 
binding, and sensory perception of light stimulus. We also observed depletion of pathways 
associated with immune function and vasculature development after CPF exposure. Additionally, 
non-specific dysregulation of pathways involving serine hydrolase activity and the extracellular 
region of cells was induced by short-term CPF exposure. Due to the interdependency of many 
physiological systems when exposed to a contaminant such as CPF, it is likely that these 
pathways are linked to one another. In some cases, the links between pathways are obvious. For 
example, pathways involved in serine hydrolase activity, tetrapyrrole and heme binding, and 
monooxygenase activity are all related to the inhibition of AChE activity which is an expected 
outcome of exposure to OP pesticides, including CPF. In other cases, the links between pathways 
may be more subtle. For example, it is possible that the multitude of effects on energy 
metabolism and metabolic processes were a more general response to the changes observed in 
more specific outcomes, such as immune function and neurological processes. Apical outcomes 
of chronic CPF exposure were also observed, including inhibition of AChE activity, increased 
liver weight relative to body weight, and a decrease in percentage of individuals that reached 
Nieuwkoop and Faber (NF) stage 65 (Nieuwkoop and Faber, 1994). In some cases, the altered 
transcriptomic pathways following ELS exposure could be related to the observed apical 
outcomes. For example, pathways related to serine hydrolase activity were dysregulated after 96 
h ELS exposure and AChE, a serine hydrolase enzyme, was inhibited in the brains of X. laevis at 
metamorphic climax after chronic exposure to 10 μg L-1 CPF. Additionally, dysregulation of 
pathways associated with immune function as well as protein and carbohydrate metabolism 




to body weight after chronic exposure to 10 μg L-1 CPF. Pathways associated with 
immunotoxicity, cardiovascular toxicity, tetrapyrrole and heme binding, and blood coagulation 
were unsurprisingly dysregulated after CPF exposure. Outcomes of CPF exposure related to 
these pathways have precedence in the literature and have been noted in amphibians or other 
aquatic vertebrates. These results strengthen the known mechanisms of action and endpoints 
associated with CPF exposure in aquatic species and provide novel data for amphibians to add to 
the relatively large amount of data for fish species. Some of the transcriptomic pathways that 
were dysregulated by CPF exposure had little or no precedence in the literature, regardless of 
taxa. These included effects on vasculature development, response to light stimulus, and effects 
on the extracellular region of cells specifically. These findings have the potential to direct new 
research into the outcomes of CPF exposure in amphibians. In Chapter 2, we demonstrated that 
short-term, ELS exposure to CPF has the potential to disrupt a range of important pathways and 
processes in X. laevis. Pathway analysis revealed disruption of biological processes and 
molecular functions which may be associated with adverse outcomes after chronic exposure 
through metamorphic climax. To our knowledge, this is the first research to assess changes in the 
ELS transcriptomic profile after CPF exposure in amphibian species. 
Immunotoxicity is a known outcome of CPF exposure in fish species; however, the 
literature regarding CPF-mediated immunotoxicity of amphibians is relatively scarce. In Chapter 
2, depletion of immune-related pathways including cytokine receptor activity, immune function, 
and inflammatory response occurred after 96 h ELS exposure to CPF.  Further examination of 
CPF-induced immunotoxicity was warranted due to the potential links between sub-lethal 
pesticide exposure, immunomodulation, and increased susceptibility to disease. In some cases, 
pesticide exposure in the environment has been linked to both localized mass mortality events, as 
well as widespread declines of amphibian populations globally (Carey et al., 1999; Hayes et al., 
2010). Therefore, research presented in Chapter 3 aimed to determine whether impacts on 
immune-related pathways after ELS exposure translated to disrupted immune function and to 
examine the potential immunomodulatory effects of CPF exposure on amphibians at the critical 
and unique transitional life stage of metamorphosis when challenged with a the known 
immunostimulatory agent, LPS. Exposure to CPF for 7 days (d) resulted in immunomodulation 
in X. laevis metamorphs as demonstrated by changes in endpoints related to immune function. 




convoluted tubules of the kidney. Circulating leukocyte populations were also affected with 
decreased lymphocytes and increased granulocytes observed after exposure to 1 μg L-1 CPF 
along with a higher granulocyte:lymphocyte (GL) ratio at 1 and 10 μg L-1 CPF. Lastly, the 
expression of pro-inflammatory cytokines TNF-α and CSF-1 in the liver increased with exposure 
to 10 μg L-1 CPF. To our knowledge, this is the first study to examine the immune-related effects 
of short-term exposure to CPF in amphibians and considering responses in an immune-
stimulated state. However, despite evidence that CPF exposure alone can alter immune 
parameters, this exposure did not appear to hinder the animal’s ability to mount an appropriate 
response to the immunostimulatory agent LPS. Following LPS injection we observed the 
characteristic responses reported in aquatic vertebrates, namely decreased circulating 
lymphocytes, increased circulating monocytes, and an increased GL ratio (Swain et al., 2008). 
We did not observe an increase in proportion of circulating granulocytes which is an expected 
response to stress in amphibians (reviewed in Davis et al., 2008). Injection of LPS also induced 
expression of pro-inflammatory cytokines, TNF-α, IL-1β, and CSF-1. Several in vitro studies 
with fish cells report that LPS stimulates macrophages to produce pro-inflammatory cytokines 
(reviewed in Swain et al., 2008) and this appears to be conserved in amphibians as well (Robert 
and Ohta, 2009). We conclude that LPS is an effective mitogen in X. laevis and is appropriate for 
usage in an immune-challenge assay as it induces a robust and measurable inflammatory 
response. Overall, we conclude that CPF exposure altered biomarkers of immune status and 
histopathological changes in X. laevis kidneys but that these observed outcomes did not 
necessarily translate into immunosuppression or impaired ability to mount an appropriate 
response to LPS exposure. 
4.3 Limitations of research and future directions 
 The nominal waterborne concentrations of CPF used in Chapter 2 (0.4, 2, and 10 μg L-1) 
were chosen based on a literature review to determine sub-lethal and environmentally relevant 
concentrations in amphibians as well as a 21-d pilot exposure to identify sub-lethal 
concentrations in X. laevis. Water samples were collected from each tank at five time points 
throughout the exposure period, and composite samples from each treatment group were 
analysed to determine actual water CPF concentrations throughout the chronic exposure. The 




recovery in the sample taken at the earliest time point in the exposure period. In the aquatic 
environment, CPF is reported to adsorb to algae (Giddings et al., 2014) and glass (Thomas and 
Mansingh, 2002). In the present study, it is possible that some of the waterborne CPF was being 
adsorbed to the algae and that this adsorption proportionally increased throughout the exposure 
period with increasing algal growth. Additionally, adsorption of the chemical to the glass 
aquaria, the glass sampling equipment, and the glass bottles used to store and ship the composite 
samples could account for further losses of measured CPF. A study by Mazanti et al. (2003) 
examined the aqueous-phase disappearance of CPF from both laboratory and field exposure 
systems. They found that CPF was rapidly lost from these systems initially, and concluded that, 
based on its physicochemical properties, CPF had a very high escaping tendency in aquatic 
systems (Mazanti et al., 2003). Measuring actual body burden of CPF within exposed individuals 
may provide a more accurate picture of the actual exposure concentrations. In addition, future 
studies using waterborne CPF over a chronic exposure period would benefit from measuring 
chemical concentration within the stock solutions as well as water samples to ensure degradation 
is not occurring in the stock solutions themselves. 
 The endpoints measured in Chapter 2 at the end of chronic exposure to CPF (at 
metamorphic climax) were pre-determined based on scientific literature and selected prior to 
knowledge of the changes in the transcriptome profiles of ELS individuals. To ensure that the 
most relevant outcomes of chronic CPF exposure were measured, apical endpoints could have 
been selected after completion of pathway analysis. This would have allowed us to target 
pathways and processes that were shown to be dysregulated after ELS CPF exposure and to 
determine if these ELS disturbances translated to apical outcomes of chronic exposure. For 
example, the immune-related effects of exposure to OP pesticides, including CPF, in aquatic 
vertebrates are becoming more widely discussed in the literature. The ELS transcriptomic profile 
showed dysregulation of a number of pathways associated with immune function after short-term 
CPF exposure. An immune challenge study measuring infection rates, morbidity, and mortality 
after chronic CPF exposure would help determine if immune-related ELS pathway dysregulation 
led to functional alteration of the immune system later in life. 
In Chapter 3, LPS injection was used as an immunostimulant and to determine whether 
CPF-exposed individuals were able to mount an appropriate immune response. 




such, the expected immune response to LPS exposure is noted in the literature (Swain et al., 
2008). Although effective in simulating a pathogen infection, LPS is not a pathogen of concern 
in an environmentally relevant scenario. Use of an environmentally relevant amphibian pathogen 
of concern, such as Ranavirus, would better reflect the immune-related outcomes of amphibians 
in a CPF-contaminated environment. In the wild, Ranavirus has been implicated in both 
localized mass mortality events as well as globally declining amphibian populations. Amphibian 
pathogen and contaminant exposure occurs simultaneously in the environment. Recent studies 
have explored the links between amphibian exposure to pesticides leading to immunosuppression 
and increased incidence of disease. Some have discussed the possibility that Ranavirus, and other 
pathogens of concern, are not emergent but rather the inability to mount an appropriate immune 
response because of pesticide exposure is what is emergent (Hayes et al., 2006). A follow up 
study examining the effects of CPF exposure on the immune response to an environmentally 
relevant pathogen, such as Ranavirus, could provide insight on the potential links between 
ubiquitous CPF contamination and increased opportunistic pathogen infection.  
4.4 Applicability of research findings 
In the research conducted in Chapter 2 of this thesis, we examined the transcriptomic 
responses to CPF exposure in ELS X. laevis. This study was a part of a large, collaborative 
research project (the EcoToxChip project) that aims to to develop and validate quantitative PCR 
arrays and a data evaluation tool (EcoToxXplorer.ca) for characterization, prioritization, and 
management of environmental contaminants in model laboratory species and native species of 
concern (www.ecotoxchip.ca; Basu et al., 2019). Specifically, the EcoToxChip project aims to 
link multi-omics endpoints (transcriptomic, metabolomic, and proteomic) after ELS exposure to 
apical outcomes of chronic exposure to contaminants of concern. The findings of this study will 
be combined with other ‘omic and apical endpoint analyses in both X. laevis and a native North 
American Ranid amphibian, Lithobates pipiens (Northern leopard frog), as well as fish and avian 
species. The observed transcriptome-level responses to CPF in ELS individuals, especially 
identification of novel dysregulated pathways not identified in previous studies, have the 
potential to drive future research into the underlying mechanisms of CPF-mediated toxicity in 
amphibians. Over the chronic exposure period, there were a number of apical outcomes that were 




associated with CPF exposure in aquatic vertebrates, such as changes in morphometric indices 
and incidence of malformation, were largely unaffected in our study. This could be attributed to 
both species and life stage differences and highlights the importance of considering amphibians 
separately when conducting toxicological research. Some of the dysregulated pathways 
identified in this study after ELS exposure to CPF could direct future research on relevant and 
novel apical outcomes of chronic CPF exposure in amphibians. These outcomes may, in some 
cases, differ from the more widely examined endpoints of CPF exposure in aquatic vertebrates 
which are largely based on studies performed in fish species.  
In Chapter 3 of this thesis, we used an exposure approach optimized in our lab where a 
short-term chemical exposure using the model amphibian species, X. laevis, is followed by an 
immune challenge using LPS as an immunostimulant. Our work shows that this exposure model 
could be effective for rapid screening of environmental contaminants for potential 
immunotoxicity and specifically their capacity to compromise an appropriate immune response. 
This approach could be used in a variety of exposure scenarios with different classes of 
chemicals, different species of amphibians, and different immunostimulatory agents or pathogens 
including environmentally relevant pathogens of concern.  
4.5 Concluding statement  
 This thesis research was conducted to gain a better understanding of the effects of CPF 
exposure on amphibians and to provide novel data on responses across levels of biological 
organization, from molecular to whole animal. The results indicate that exposure to CPF can 
affect endpoints across a range of physiological parameters at all levels of biological 
organization, suggesting that CPF exposure in aquatic environments poses a threat to amphibian 
species. These findings add to the growing body of evidence regarding the potential links 
between pesticide contamination, opportunistic infection leading to disease, and global 
amphibian declines and overall highlight the importance of considering amphibian species when 









Appendix A: Mean (± SEM) for water quality parameters measured over the chronic chlorpyrifos (CPF) exposure period. Parameters 












   CPF Concentration (μg L-1) 
 Facility Water 0.01% DMSO 0.4 2 10 
Temperature (ºC) 21.72 ± 0.04 21.60 ± 0.05 21.48 ± 0.05 21.62 ± 0.04 21.56 ± 0.05 
pH 7.96 ± 0.03 7.97 ± 0.04 7.99 ± 0.04 7 .97 ± 0.04 7.95 ± 0.04 
Dissolved Oxygen (%) 75.87 ± 1.40 77.13 ± 1.41 78.88 ± 1.13 77.66 ± 1.04 77.94 ± 1.17 
Ammonia (ppm) 0.53 ± 0.04 0.50 ± 0.04 0.54 ± 0.04 0.54 ± 0.04 0.53 ±0.04 
Nitrate (ppm) 0.99 ± 0.01 0.99 ± 0.01 0.99 ± 0.01 0.99 ± 0.01 0.99 ± 0.01 
Nitrate (ppm) 0.05 ± 0.00 0.05 ± 0.00 0.07 ± 0.02 0.05 ± 0.00 0.05 ± 0.00 
Hardness (ppm) 179.88 ± 0.22 180.12 ± 0.19 180.08 ± 0.38 179.80 ± 0.12 179.96 ± 0.04 
Alkalinity (mg/L) 122.33 ± 0.55 122.08 ± 0.48 122.32 ± 0.48 122.24 ± 0.53 122.49 ± 0.56 







Appendix B: (A) Table displaying all significantly altered (p ≤ 0.05) Gene Ontology (GO) terms after 96 h chlorpyrifos (CPF) 
exposure in early life-stage X. laevis. The term p values were corrected with a Bonferroni step down. (B) ClueGo visualization of 
functionally grouped networks formed from significantly (p ≤ 0.05) altered pathways based on GO databases. Pathways were built 
using at least 5 differentially expressed genes (p ≤ 0.05) in early life-stage X. laevis after 96 h of CPF exposure. Statistical test was set 
to a right-sided hypergeometrical test with a Bonferroni (step down) p-value correction and a kappa score of 0.4. Node size represents 
pathway significance and darker shades represent higher gene proportion associated with pathway. Green node = depleted pathway, 
gray node = un-specific pathway, red node = upregulated pathway. Text colour has been changed for clarity.  
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sensory perception of light stimulus GO:0050953 0.01 [5] 11.76 10.00 Upregulated 
tetrapyrrole binding GO:0046906 0.00 [3] 11.71 24.00 Upregulated 
heme binding GO:0020037 0.00 [3,4] 11.50 23.00 Upregulated 
monooxygenase activity GO:0004497 0.00 [4] 12.41 17.00 Upregulated 
oxidoreductase activity, acting on paired donors GO:0016705 0.00 [4] 9.28 18.00 Upregulated 
monosaccharide metabolic process GO:0005996 0.00 [3,4] 15.25 9.00 Upregulated 
hexose metabolic process GO:0019318 0.00 [4,5] 16.36 9.00 Upregulated 
monosaccharide biosynthetic process GO:0046364 0.00 [4,5] 30.43 7.00 Upregulated 
glucose metabolic process GO:0006006 0.00 [5,6] 21.88 7.00 Upregulated 
hexose biosynthetic process GO:0019319 0.00 [5,6] 30.43 7.00 Upregulated 
blood coagulation GO:0007596 0.00 [3,5] 25.00 14.00 Upregulated 
response to wounding GO:0009611 0.00 [3] 20.59 14.00 Upregulated 
regulation of body fluid levels GO:0050878 0.00 [3] 22.58 14.00 Upregulated 
hemostasis GO:0007599 0.00 [4] 25.00 14.00 Upregulated 
wound healing GO:0042060 0.00 [4] 22.58 14.00 Upregulated 







negative regulation of macromolecule metabolic 
process 
GO:0010605 0.00 [3,4,5] 8.05 31.00 None Specific 
negative regulation of cellular metabolic process GO:0031324 0.00 [3,4,5] 8.96 30.00 None Specific 
negative regulation of molecular function GO:0044092 0.00 [3] 11.26 26.00 Upregulated 
negative regulation of nitrogen compound 
metabolic process 
GO:0051172 0.00 [3,4,5] 9.23 30.00 None Specific 
negative regulation of protein metabolic process GO:0051248 0.00 [4,5,6] 12.44 27.00 None Specific 
negative regulation of cellular process GO:0048523 0.00 [2,3,4] 6.70 40.00 Upregulated 
negative regulation of catalytic activity GO:0043086 0.00 [4] 12.21 26.00 Upregulated 
enzyme inhibitor activity GO:0004857 0.00 [5] 12.92 23.00 Upregulated 
negative regulation of hydrolase activity GO:0051346 0.00 [5] 13.79 20.00 Upregulated 
regulation of proteolysis GO:0030162 0.00 [5,6] 14.71 20.00 Upregulated 
regulation of peptidase activity GO:0052547 0.00 [5,6,7] 16.67 20.00 Upregulated 
negative regulation of proteolysis GO:0045861 0.00 [5,6,7,8] 17.09 20.00 Upregulated 
peptidase regulator activity GO:0061134 0.00 [5,6,7,8] 17.09 20.00 Upregulated 
cytokine receptor activity GO:0004896 0.03 [5,6,7] 12.90 8.00 Depleted 
defense response GO:0006952 0.03 [3] 8.84 13.00 Depleted 
inflammatory response GO:0006954 0.00 [4] 14.67 11.00 Depleted 
positive regulation of response to stimulus GO:0048584 0.00 [2,3,4] 10.16 19.00 None Specific 
activation of immune response GO:0002253 0.00 [2,4,5,6] 15.52 9.00 None Specific 
positive regulation of immune system process GO:0002684 0.02 [2,3,4] 12.16 9.00 None Specific 
positive regulation of immune response GO:0050778 0.01 [3,4,5] 13.43 9.00 None Specific 
cardiovascular system development GO:0072358 0.02 [4,5,6] 14.89 7.00 Depleted 
vasculature development GO:0001944 0.02 [4,5,6,7] 14.89 7.00 Depleted 
regulation of immune response GO:0050776 0.02 [3,4] 11.11 10.00 Depleted 
Serine hydrolase activity GO:0017171 0.00 [3] 9.09 25.00 None Specific 

















Appendix C:  Water quality parameters measured over a 7  day exposure of metamorphic 
Xenopus laevis to chlorpyrifos (CPF).  
  CPF Concentration (μg L-1) 
 0.01% DMSO 1 10 
Temperature (ºC) 21.50 ± 0.10 21.35 ± 0.08 21.48 ± 0.11 
pH 7.91 ± 0.23 7.97 ± 0.22 7.98 ± 0.22 
Dissolved Oxygen (%) 87.54 ± 2.21 90.44 ± 1.53 88.16 ± 1.98 
Ammonia (ppm) 0.78 ± 0.11 0.84 ± 0.10 0.78 ±0.11 
Nitrate (ppm) 0.92 ± 0.08 1.00 ± 0.00 0.92 ± 0.08 
Nitrate (ppm) 0.07 ± 0.02 0.05 ± 0.00 0.05 ± 0.00 
Hardness (ppm) 180.00 ± 0.00 180.00 ± 0.00 180.00 ± 0.00 
Alkalinity (mg/L) 120.00 ± 0.00 120.00 ± 0.00 120.00 ± 0.00 
Conductivity (µS/cm) 464.46 ± 2.80 464.16 ± 2.77 465.08 ± 2.52 
Parameters were measured from each tank every two days over the exposure period (4 



















Appendix D: Morphometric parameters following 7 day exposure to chlorpyrifos (CPF) and 
PBS or LPS injection in metamorphic Xenopus laevis. 




Weight (mg g-1) 
0.01% DMSO  PBS 1.665 ± 0.444 24.87 ± 2.08 0.032 ± 0.005 
 LPS 1.501 ± 0.479 24.24 ± 2.09 0.037 ± 0.006 
1 μg L-1 CPF PBS 1.485 ± 0.582 23.71 ± 3.62 0.037 ± 0.009 
 LPS 1.486 ± 0.509 24.10 ± 2.51 0.038 ± 0.008 
10 μg L-1 CPF PBS 1.568 ± 0.549 24.27 ± 2.71 0.034 ± 0.005 
 LPS 1.386 ± 0.489 23.42 ± 2.70 0.039 ± 0.007 
Data are presented as mean ± SEM (n=9-10 individuals/treatment). 
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